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SUMMARY
Between June 1984 and June 1986 a variety of studies on 
rotavirus diarrhoea and its prevention were conducted in 
Bakau, a peri-urban Gambian community. This thesis reports 
the results of these studies and places them in the context 
of current knowledge concerning the epidemiology and 
immunology of rotavirus infection.
Short, well-demarcated epidemics of rotavirus diarrhoea were 
observed in this study during two consecutive cool dry 
seasons in The Gambia. This very clear seasonal pattern has 
now been documented for four consecutive years. During the 
1985/86 epidemic transmission was intense with an attack 
rate for infants of 36%. It was estimated that asymptomatic 
virus shedding in stools was two thirds as common as 
symptomatic infection. Rotavirus diarrhoea was more severe 
than diarrhoea due to all other causes and clinical 
rotavirus infection was associated with weight loss in the 
post-infection period. Non - epidemic periods were 
characterised by very occasional mild cases and asymptomatic 
virus shedding in neonates. There was a change in R.N.A. 
electropherotypes from a predominantly long pattern in 
1983/84 and 1984/85 to short patterns in 1985/86.
A case-control study was conducted on 92 cases and 92 age 
and vaccine statusjhnatched controls to determine social and 
environmental risk factors for rotavirus infection. No risk 
factors were found but there was an association between 
rotavirus cases and the presence of a dog in the child’s 
compound.
A randomised, double blind, placebo controlled trial of the 
bovine rotavirus vaccine KIT 4237 was undertaken in young 
Gambian children. Three doses of rotavirus vaccine were 
administered, commencing at the age of ten weeks, 
concurrently with oral or killed poliomyelitis vaccine. Pre­
vaccination rotavirus neutralising antibody levels were 
high. 84/185 infants (45%) showed an increase in 
neutralising antibody titre after receiving rotavirus 
vaccination, compared with 20/91 (22%) of unvaccinated
infants. During 14 months of observation, clinical
rotavirus infection was detected in 24/78 (31%) children in 
the rotavirus/oral polio group, in 34/83 (41%) children in 
the placebo/oral polio group, and in 23/92 (25%) children in 
the rotavirus/killed polio group, giving an overall vaccine 
efficacy of 33% (95% C.I. 4% to 53%). KIT 4237 did not 
reduce the severity of clinical infections. No effect from 
the concurrent administration of oral polio vaccine on the 
immune response to rotavirus vaccine was observed. Lower 
type 1 and type 3 polio antibody levels were found in
children who received oral polio and rotavirus vaccines than
those who received oral polio vaccine and placebo but
differences between the two groups were not statistically
s ign i f icant.
A number of possible explanations for the poor efficacy of 
KIT 4237 are considered. High maternal antibody levels to 
rotavirus at the time of vaccination may have reduced the 
immune response to vaccination. Another possibility is that 
Gambian breast milk contains anti-rotavirus antibody or non­
antibody factors which inhibited the vaccine response. In
14
addition, naturally circulating enteroviruses may have 
interfered with the immune response to the rotavirus 
vaccine.
In anticipation of the development of a successful rotavirus 
vaccine, factors leading to poor vaccination compliance were 
investigated. The vaccination status of 251 children aged 12 
- 18 months living in Bakau was determined from their health 
cards. Two subgroups were identified: children who were
fully vaccinated, and those who had received less than half 
their vaccinations. The social and environmental 
circumstances of these children were investigated. In the 
poorly vaccinated group both parents were less well educated 
and there was a trend towards poorer literacy. Mothers of 
poorly vaccinated children had a poorer knowledge of the 
diseases their children should be vaccinated against and had 
a more superstitious view of disease causation. Those 
children who showed poor compliance came from larger 
families. Mothers of well vaccinated children were more 
inclined to bring them for non-curative services.
The implications of the above findings for further research 
into rotavirus and diarrhoeal disease in general are also 
considered.
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Whooping
CHAPTER I
INTRODUCTION
This thesis reports the results of a series of studies 
concerned with the prevention of rotavirus diarrhoea in The 
Gambia, The Gambia is a poor country which faces many health 
and nutritional problems. Government spending on health is 
low (estimated at less than £3 per person, per year). Such 
a severe lack of funds inevitably leads to shortages of 
manpower and equipment but, despite these constraints, much 
has been accomplished in recent years.
My own work was conducted under the auspices of the Medical 
Research Council (M.R.C.) which gave me access to some of 
the resources necessary to carry out a sophisticated 
research project but it was clearly vital that the my work 
should be relevant to the needs of the Gambian people. 
Diarrhoeal disease had been identified in 1980 by the 
Gambian Government as a health priority and the following 
year a Diarrhoeal Disease Control Committee was established. 
The committee’s main priority has been to establish oral 
rehydration as the first line treatment for all episodes of 
diarrhoea. Initially the M.R.C.*s contributed to the 
diarrhoea control effort by mounting a major study to 
investigate the aetiology of diarrhoea. Unfortunately this 
work proved somewhat unrewarding as the majority of 
diarrhoeal cases were not associated with pathogens which 
could be identified with techniques available in the country 
at that time. The committee, therefore, requested that the
17
next phase of research should concentrate on aspects of 
prevention. As a result, research efforts were directed 
towards rotavirus associated diarrhoea because there was a 
realistic prospect of preventing this condition through 
vaccination.
Childhood Diarrhoea in the Developing Wor^d..
The impact of childhood diarrhoeal disease throughout the 
developing countries of Asia, Africa and South America is 
truly staggering. In several published studies, diarrhoea 
has been shown to be the major cause of early childhood 
death, (1,2,3) and in 1982 the World Health Organization 
(W.H.O.) estimated that in children under five years of age 
there were 4.6 million deaths a year attributable to 
diarrhoea (4). These mortality statistics reflect much 
heavier burdens of morbidity. Children suffer the greater 
burden of disease as investigations worldwide have found 
diarrhoea incidence peaking between the ages of 6 months and 
3 years, with an annual rate ranging from 2 to 12 episodes, 
averaging 4 per year in most poor communities (5,6,7,8). The 
impact of these global statistics at the community level was 
elegantly illustrated by Chen who calculated that a village 
health worker, who might commonly be responsible for 
delivering health care to a target population of 5,000, 
would have to deal with 8 new cases of gastroenteritis each 
day and, that on any given day, roughly 75 children would be 
experiencing diarrhoea (9).
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Diarrhoea threatens the lives of children in two main ways. 
Fluid loss leading to dehydration is the acute threat, but 
repeated acute attacks or chronic diarrhoea will also lead 
to weight loss, growth faltering, and malnutrition (9,10,11, 
12).
In recognition of the threat posed by diarrhoeal diseases 
the World Health Organization has initiated a global 
Diarrhoeal Disease Control Programme, the objectives of 
which are to reduce diarrhoeal morbidity and mortality. One 
of the first tasks of this programme was to fund a variety 
of aetiological studies to establish the major pathogens 
responsible for gastroenteritis in the Developing World. 
These studies have shown that rotavirus and enterotoxigenic 
Escheri_chi_a col_i_ (!£._ col.i.1 are the two major pathogens 
associated with childhood diarrhoea worldwide (13,14).
and Childhood Diarrhoea^
Before 1972 there was a high index of suspicion, but no 
direct evidence, that much gastroenteritis in humans was due 
to viral infections (15). Many large surveys in the more or 
less "developed" countries showed that as many as two-thirds 
of all diarrhoeal episodes were of unknown aetiology. In 
April 1973 electron microscopy revealed virus-like particles 
in an ultra thin section of an epithelial cell from the 
duodenum of a child suffering from acute gastroenteritis 
(16). The new virus was called rotavirus because its capsid 
structure suggested the spokes of a wheel, and "rota" is the 
Latin word for a wheel (fig 1). Since then rotavirus has
19
FIGURE 1
Electron micrograph of rotavirus.
WWvt iMi^voy^pk, ?
Magnification x 200,000, stain P.T.A., pH 7.
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established itself as the single most important , childhood 
diarrhoeal pathogen (17,18,19). Rotavirus is the cause of 
acute diarrhoea in approximately 40% of children requiring 
hospital admission in developing countries, (20 - 25) and in 
50 - 60% of children admitted to hospital in industrialised 
countries (26 - 31). Community surveys have been less
numerous, but they consistently give lower rates of 
rotavirus infection than hospital studies, a fact which 
probably indicates the relative severity of rotavirus 
compared to other diarrhoeal pathogens (14,32).
The Ep_idemio_logy of Rotavirus..
Rotavirus infection has a worldwide distribution, affecting 
all age groups but symptomatic attacks are largely confined 
to young children (17,18,33 - 37). Serological surveys
indicate that most primary infections occur during the first 
two years of life in both industrialised and developing 
countries (33 - 37), but frequent asymptomatic infections 
occur in older children and adults who come in contact with 
infected children (38,39).
The attack rate for rotavirus disease is remarkably similar 
in children in developed and developing countries, despite 
the fact that the attack rate for diarrhoeal diseases as a 
whole is up to seven times greater in developing countries 
(40 - 45). The attack rate for rotavirus diarrhoea in
children aged 6 - 2 4  months has been estimated at 0.3 - 0.8 
episodes per child per year in both settings 
(40,41,42,46,47). This fact is relevant to discussions
21
concerning the need for a rotavirus vaccine because in
countries with a heavier burden of diarrhoeal disease the
importance of rotavirus diarrhoea might be underestimated
simply because it makes up a smaller proportion of the 
whole. It is, therefore, more meaningful to discuss age 
specific clinical attack rates as this gives an indication 
of the proportion of children who are at risk from the 
dangers of clinical rotavirus infection and are therefore 
likely to benefit from vaccination.
This consistency of incidence and attack rates through a 
wide variety of environments has led some to speculate that 
the mode of rotavirus transmission is different from other 
enteric pathogens. Rotaviruses infect the small intestine 
via the oral route. Multiplication occurs within mature 
epithelial cells lining the villi of the upper portion of
the small intestine, causing lysis of cells and release of 
infectious particles into the intestinal lumen (48). 
Infection in man seems to be restricted to the small
intestine and there is no direct evidence of infection in
the respiratory tract (49). The primary mechanism of spread 
is probably intra-fami 1ial (38,39,50), via faecal-oral 
contamination, but airborne spread of dust or droplets 
carrying virus particles is also a possibility, as is
infection via contaminated food or water (51).
The incubation period is 24 - 48 hours and the onset of
illness is abrupt with watery diarrhoea causing a greater 
degree of dehydration and fever than with most other enteric
22
pathogens (17,18,19,32,44). Vomiting, which is a frequent 
early feature of the disease, increases the degree of 
dehydration. Host children excrete rotavirus, in amounts 
detectable by electron microscopy (fig 1), for 5 days 
following the onset of symptoms.
Seasonal variation in rotavirus infection is complex and
presently unexplained. Comparison of monthly incidence in 
hospitalised children indicates that infection is endemic in 
most communities. In areas with extreme fluctuations in 
climate between winter and summer months, rotavirus seems to 
be epidemic in the winter (27,29,52). In more temperate 
climates rotavirus peaks in the winter months but is present 
throughout the year (26,31), while in tropical areas either 
no seasonal fluctuation is seen (-49) or modest peaks 
associated with cooler dryer months are observed 
(49,19,24,25). The epidemic nature of rotavirus in The
Gambia is striking and will be described in detail later in 
the text. Recent studies have indicated that atmospheric 
humidity and temperature have an influence on rotavirus 
survival on fomites (53). It was found that the Wa strain of 
human rotavirus survived longer on non-porous surfaces at 
lower temperatures and lower humidity and it is possible
that this phenomenon may partially explain the association 
between climate and clinical illness.
Rotavirus infection in neonates is common but is usually 
mild or asymptomatic (44,54 - 66). Infection is particularly 
common in hospital nurseries where the aggregation of babies 
and attendant adults seems to enhance the possibility of
23
spread from infected children. In contrast, neonatal 
infection is relatively rare in children born at home (42) 
or at village health centres (19). Antirotavirus antibodies 
have been demonstrated in cord blood and breast milk but 
breast feeding seems to provide only partial protection from 
neonatal rotavirus infection (66,67).
As stated previously, severe clinical disease is largely 
confined to children aged between 6 - 2 4  months (34,35,37) 
but, even in this age group, asymptomatic infection can be 
common (40,42,67,). In children less than two years old, 
sequential clinical infections have been observed (42), but 
it is not clear how frequently this occurs, nor whether 
reinfection occurs more commonly with heterotypic than 
homotypic serotypes of the virus (68).
Symptomatic rotavirus infection is rare but can occur in 
older children and adults (46,49,64,69,70,71).
A number of serologically distinct strains of rotavirus 
exist and these are described later. However, serological 
strain typing is performed as a research investigation only 
in reference laboratories. To date most epidemiological 
surveys of rotavirus strains have relied largely upon 
analysis of patterns formed when the 11 segments of double 
stranded R.N.A. contained in the virus genome are separated 
by polyacrylamide gel electrophoresis (PAGE) (72). Human 
rotaviruses show characteristic groups of R.N.A. segments, 
whereby 1-4, 5-6, 7-9, 10-11 migrate as separate groups.
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These result in a number of migration patterns 
("electropherotypes") which divide conveniently into those 
which show a short (S), and those which show a long (L) 
electropherotype. Figure 2 shows the long electropherotype 
(L) and the the three short electropherotypes (Sa, Sb and 
Sc) detected during the 1985/86 epidemic. Note that it is 
the variable migration of the segments 10 and 11 which 
determines whether the virus has a short or long 
electropherotype. The photograph also includes the vaccine 
virus electropherotype which is distinct from human 
rotavirus isolates, being derived from a bovine rotavirus 
strain. In general, multiple electropherotypes exist 
simultaneously in most closely populated communities (73 
79) but, usually, one or two electropherotypes are dominant 
in any single outbreak and sometimes the dominant 
electropherotype is detected in small numbers for several 
months before it becomes dominant (73,78).
Some Immunological Aspects of Rotavirus Infection^
Rotaviruses belong to the family of viruses known as 
Keoviridae and are classified as a genus within a family 
(19,51). The virus particles are made up of two concentric 
icosahedral protein capsids enclosing 11 segments of genomic 
double-stranded R.N.A.(80). Until recently, it was thought 
that all known rotaviruses possessed a common group-specific 
antigen. However, evidence is now accumulating that there 
are strains of rotaviruses infecting man, animals, and 
birds, which do not share this common antigen (81) and are 
consequently not detectable by the presently available
FIGURE 2
Photograph of the long electropherotype (L) together with 
the three short electropherotypes (Sa, Sb and Sc) found in 
rotaviruses detected during the 1985/86 epidemic in Bakau. 
The vaccine virus electropherotype (V) is also included.
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serological tests. The original rotaviruses have now been 
designated group A. The newer strains are called groups B 
to E. The vast majority of human infections seem to be 
caused by group A viruses. Rotaviruses may be further typed 
by serological methods (81,82,83,84). Subgroup specificity 
is determined by an antigen located on the inner capsid of 
the virus particle. Two subgroups (I and II) have been 
identified. The antigen which determines serotype is found 
on the outer capsid. This antigen also determines 
neutralising specificity and, to date, six separate
serotypes have been identified (81,85,86). A summary of 
rotavirus classification is shown on Table I.
The relationship between R.N.A. electropherotype and 
subgroup/serotype is such that a short R.N.A. pattern is 
generally found in subgroup I serotype 2 viruses, while a 
long pattern is associated with subgroup II serotypes 1 and 
3. These associations are based on a relatively small number 
of observations and, at present, can only be described as 
provisional.
Diagnosis of rotavirus infection is most commonly performed 
by an Enzyme-Linked Immunosorbent Assay (E.L.I.S.A.) which 
relies on recognition and binding to the common group
antigen (87), or by direct visualisation in the electron
microscope.
Immunity to disease associated with rotavirus infection is 
not fully understood but seems to rely on an amalgamation of
27
Table I
Classification of rotaviruses.
Method Determinant Examples
of for
classification classification
Group Common A,B,C,D,E.
group
antigen
Subgroup Inner I, II
capsid
antigen
Serotype Outer 1,2,3,4,5,6.
capsid 
ant igen
Electropherotype R.N.A. long
migration short
pattern
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passive and active immunity, superimposed on non-specific 
resistance mechanisms (17,88,89,90). Newborn babies are at 
least partially protected by maternally derived antibody in 
the blood together with antibodies and non-antibody factors 
ingested in breast milk (91,92). Neither mechanism is 
foolproof, as breast-fed children and those with high levels 
of maternal antibody can become symptomatic (93). This 
enigma may be resolved when neutralising antibody in breast 
milk and serum are titrated and related to the serotype of 
the infecting virus.
It has been shown in animal hosts and animal models that 
passively acquired antibody can protect neonates against 
diarrhoea caused by rotavirus (94), provided that enough 
specific antibody with neutralising activity is present 
continuously in the small intestine of the host. Passive 
immunity is being used with success to prevent rotavirus 
diarrhoea in calves, through vaccination of the dam to 
stimulate increased and prolonged secretion of antibody in 
colostrum and milk (95).
In studies conducted on children, treatment with either 
human serum gammaglobulin or colostrum and milk globulin 
derived from cows vaccinated with human rotavirus resulted 
in only partial protection (96). As with animals, a better 
protective effect was obtained in infants when rotavirus 
antibodies were given prophylactically. The efficacy of the 
therapeutic and prophylactic use of preparations conveying 
passive immunity in man has not been established but merits 
further investigation.
Babies infected with rotavirus lo^se maternally derived and 
naturally acquired antibodies with time (61) and are not 
immune to reinfection with rotavirus, although they do 
suffer less severe clinical infections (67). This indicates 
that they have retained a degree of immunity to rotavirus 
which prevents severe clinical disease when reinfection
occurs during the first few years of life (67).
It is not clear at present which part of the immune response 
is the most protective against clinical rotavirus infection. 
It has been shown in man and various animal models that IgG, 
IgM and IgA antibodies are produced in response to rotavirus 
infection (89). Host investigators, however, seem to be
agreed that in humans, of all the parameters of immunity to
rotavirus, local gut immunity appears to have the greatest 
protective role (88,89,90). Studies carried out on animals 
have also pointed to the importance of local gut immunity 
(93,97,98). This was shown in an experiment where colostrum 
containing rotavirus antibody was fed to lambs on the first 
day of life but, when the lambs were challenged on the next
day with lamb rotavirus, they developed severe diarrhoea 
despite the presence of serum rotavirus antibody (acquired 
from the colostrum) on the day of challenge. In contrast, 
lambs which were fed colostrum for the first four days of 
life and challenged with rotavirus on the second day of life 
did not develop illness (93).
Although the local and systemic immune systems can function 
relatively independently it is much more convenient to 
measure the serum response to rotavirus infection than try
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to estimate intestinal IgA which would require much more 
invasive techniques. The disadvantage of measuring serum 
antibody is that there are a number of different techniques 
for measuring antirotavirus antibody and not all are equally 
useful for predicting protection from subsequent infection. 
Complement fixing antibody does show some correlation with 
clinical protection (99) but the best results seem to be 
obtained when neutralising antibody is measured against the 
four major serotypes known to cause infection in man (68). 
The antigen which defines the serotype also determines 
neutralising specificity and antibody levels measured in 
this way have been shown to predict accurately the level of 
protection from subsequent homotypic and, to a lesser 
extent, heterotypic infection (68).
The relationship between the age specificity of clinical
rotavirus infection and immune status is also poorly 
understood. As was stated above, sequential infections do 
occur in the first few years of life, which may indicate 
that protective immunity from one infection is imperfect or 
that it is serotype specific. By the age of three years 
almost all children have detectable serum antibody to 
rotavirus (33 - 36) and no longer suffer from clinical
episodes of rotavirus infection. This age specificity may 
not, however, be the simple result of acquired immunity
because evidence is emerging, in an animal model, of 
specific virus receptors on the gut mucosa which are age
dependent (100).
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Chj.ld.hood Diarrhoea in The GaraM
Diarrhoea is an established problem in The Gambia and, as in 
most developing countries, children less than 5 years of age 
are most frequently affected (101 - 104). Diarrhoea is
common throughout the year but the prevalence of acute and 
chronic diarrhoea is greatest during the rainy season (fig. 
3) (101). There is, however, a smaller peak in acute
diarrhoeal prevalence during the dry season.
The importance of diarrhoeal disease is further illustrated 
by unpublished Gambia Government figures which indicate that 
15% of all "under-fives" consultations at government clinics
children suffer an acute attack of diarrhoea during the 
course of any given two week period. The equivalent figure 
for the dry season is 15%. The accuracy of these figures is 
open to question but a rigorous prospective survey of 
children under the age of 2 years has shown just how common 
diarrhoea is, in as much as children under the age of two 
years were found to suffer from an average of 7 - 8 episodes 
per year (102).
As might be expected with such a common condition most 
attacks are mild and it is the exceptional case which 
requires hospital admission or is life-threatening. More 
severe episodes do, however, occur. This is evident from the 
fact that 8% of paediatric hospital admissions are caused by 
diarrhoea (104). Further evidence of the importance of 
diarrhoea was discovered during a recent survey of childhood
c during the rainy season, 30% of
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FIGURE 3
Monthy variation in clinic attendance due to diarrhoea at 
Keneba clinic, The Gambia (101).
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deaths conducted in rural Gambia during which diarrhoea was 
shown to be the third most common cause of death, after 
malaria and acute lower respiratory tract infection (105).
Diarrhoea in The Gambia is also almost exclusively 
responsible for the non-dietary element in failure to grow 
(10,106 - 108). Consequently, any intervention which
succeeded in reducing the prevalence of diarrhoeal disease 
would reduce fatalities associated with marasmus.
Diarrhoea is, therefore, important for three main reasons. 
Firstly, it is exceedingly common and accounts for a large 
proportion of the clinical load placed on the child health 
services. Secondly it is a major cause of childhood 
mortality and thirdly, it also contributes to the even 
larger problem of malnutrition.
Preventing Diarrhoea in The Gambia
The search for effective preventive measures for the control 
of diarrhoea in The Gambia has not been an easy one. 
Historical evidence from Europe shows that the prevalence of 
diarrhoea falls as living standards rise. The provision of 
clean water and good sanitation are obviously vital but 
there is little prospect of these improvements coming to The 
Gambia in the near future. Others have tried to identify 
single interventions which would reduce the spread of 
diarrhoea. To this end, an investigation was undertaken to 
determine the relationship between social and environmental 
variables and diarrhoea in an urban area of The Gambia
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(109). The results showed a considerable variation between 
individual children with respect to the frequency of 
diarrhoea, but none of the social and environmental 
variables recorded showed a significant relationship with 
diarrhoea prevalence. This study suggested that single 
public health interventions were not likely to improve » 
health status but rather highlighted the need for a general 
rise in living standards, education and access to health 
care. However, one weakness of this study was the fact that 
diarrhoea was treated as a single disease entity rather than 
a symptom which could be caused by a wide variety of
pathogens.
A more fruitful approach to the prevention of diarrhoea
might be to identify the important aetiological agents and 
concentrate efforts on the control of specific pathogens. 
The problem with this approach in The Gambia has always been 
the lack of knowledge concerning the aetiology of diarrhoea.
The Aetiology of Diarrhoea in The Gambia.
Efforts had been made between 1970 and 1975 to discover the 
aetiology of diarrhoea in The Gambia (101). These studies, 
which were conducted in rural Gambia, resulted in remarkably 
low yields of diarrhoeal pathogens ( 5.6% of cases and 3.5% 
of controls). One of the main reasons for this was the lack
of facilities which would have allowed the investigators to
test for toxin producing Eb coli or rotavirus. They did, 
however, highlight an epidemiological observation which was 
to prove important in the study of rotavirus. Peak diarrhoea
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prevalence coincided with the period of highest rainfall, 
but a smaller, cool, dry season epidemic was also observed* 
During this dry season outbreak severe acute dehydration was 
a feature (110)* Retrospective scrutiny of records made some 
10 to 15 years earlier indicated that this second peak was 
not just a recent phenomenon*
The first study to search systematically for E._ col.i and 
rotavirus was conducted during 1981 and 1982 in Bakau, a 
peri-urban community (102)* Table II summarises the 
important findings from this study* From these data it can 
be seen that toxigenic E*_ col.i and rotavirus were the two 
most commonly identified pathogen. Indeed they were the only 
pathogens which could be positively associated with 
diarrhoea. The bacteria and or viruses which were identified 
were associated with diarrhoea in only 27.5% of cases while 
control stools had pathogens in 19% of the samples* In 
symptomatic children less than six months of age, pathogens 
were identified in diarrhoeal stools in less than 10% of 
cases. It would not be unreasonable to argue from these 
figures that the aetiology of diarrhoea in this Gambian 
community is largely unknown.
This state of ignorance leaves ample scope for speculation 
as to the aetiology of diarrhoea in the majority of cases* 
Diarrhoeal episodes of unknown aetiology are almost 
certainly a mixed bag of infections due to a variety of 
organisms as well as some cases of diarrhoea which result 
from infection elsewhere in the body (e.g. malaria). Of 
these possibilities, diarrhoea viruses are of particular
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Table II
Isolation of individual enteropathogenic bacteria and 
viruses in diarrhoea CD) and control (C) specimens,
collected from children aged 0 - 2 4  months in Bakau, The 
Gambia.
Goh et al. 1985 (102).
Morbidity Status
Organisms Identified D C
Toxigenic E._cqii 51 41
Rotavirus 30 10
Campylobacter 22 48
Salmonella 6 18
Shigella 8 6
Mixed 25 9
Total Examined 516 695
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importance to this study as a number of other viruses have 
now been associated with diarrhoea* These include small 
round structured viruses such as Norwalk agent, astrovirus 
and calicivirus as well as coronavirus and adenovirus. With 
the exception of the “fastidious" faecal adenoviruses type 
40,41, these other viruses are less well established as 
major diarrhoeal agents in man. It is clear that a
comprehensive assessment of "infectious" diarrhoea would 
require a tremendous technical effort outside the scope of 
many developing countries. For my own study, there were 
logistic and financial problems which made a more
comprehensive assessment impossible. I was, however, able to 
set up a small collaborative exercise with Dr. David Cubitt 
which allowed some samples to be examined by E.M. in London.
Although such practical difficulties should not, in theory, 
influence academic decisions, the choice, in reality, lay 
between adopting the policy of only testing the stools for 
rotavirus or not doing the study at all. There were, 
however, major problems associated with my acceptance of 
this compromise. In a community in which diarrhoea is common 
and asymptomatic episodes of rotavirus infection are known 
to occur the presence of rotavirus in a diarrhoeal stool 
does not in any way prove causation. As a consequence, in
this presentation, the term rotavirus diarrhoea denotes 
rotavirus associated diarrhoea. In addition, the compromise 
I adopted meant that I would have no knowledge of the 
frequency with which mixed infections occurred and I would 
be able to say very little about the microbiological 
background against which the vaccine trial was performed.
I do, however, feel that the decision can be defended on 
academic as well as simply pragmatic grounds. Firstly, 
rotavirus is now well established as a pathogen and, as will 
be seen later in the text, the clinical episodes associated 
with rotavirus in The Gambia were distinctive in terms of 
their severity and timing. Secondly, the design of the 
rotavirus vaccine trial allowed for a comparison between 
groups such that mixed infections (although undetected by my 
methodology) were probably equally represented in vaccinated 
and control groups. My inability to calculate vaccine 
efficacy with and without the inclusion of mixed infections 
was a handicap but this was somewhat offset by the fact that
it was decided from the outset that it would only be
practical to introduce rotavirus vaccination into countries 
like The Gambia if the vaccine were to have a very high 
efficacy so any minor miscalculation of vaccine efficacy 
would not be of major practical importance.
One further problem was the fact that it is almost certainly
the case that children in The Gambia have a considerable
load of infection with enteroviruses. Concurrent enterovirus 
infection is thought by some to have a detrimental effect on 
the response to the oral polio vaccine and so, by the same 
logic, might have a similar effect on the oral rotavirus 
vaccine. This important issue will also be discussed in more 
detail later in the text.
Rotavi_rus i_n The Gambia.^
It is easy to both overestimate and underestimate the
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importance of rotavirus infection in The Gambia. There is a 
local tradition which speaks of severe diarrhoea occurring 
during the cool dry season and experienced clinicians had 
for many years observed a peak in admissions due to 
dehydrating diarrhoea during the dry season but it was not 
until a longitudinal study was conducted on 126 children in 
Bakau during 1981-82 that rotavirus was for the first time 
defined as an important pathogen in The Gambia (44). During 
this study well defined epidemics were observed during two 
consecutive cool dry seasons. During this study cases were 
almost entirely confined to infants after the age of 1 
month.
This study also showed that rotavirus was the second most 
commonly identified cause of diarrhoea. However, since the 
incidence of diarrhoea due to all causes is so high, it is 
only if an organism is capable of infecting the same child
several times in the same year that its frequency as an
aetiological agent would rise much above 10%. With that in 
mind, it is probably true to say that rotavirus diarrhoea is 
as common in The Gambia as diarrhoea due to any single 
pathogen is likely to be.
At about the same time that rotavirus was first shown to be 
an important cause of diarrhoea in The Gambia, results were 
published from a trial of a new bovine rotavirus vaccine. 
This trial had been carried out in Finland (111) but, 
despite the apparent success of the Finnish trial, it was
clearly important to establish that the new vaccine would
have an equally protective effect in developing countries
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where the infecting dose of virus would be higher and the 
environment so different. Therefore, a clinical trial of 
this new rotavirus vaccine, conducted in the tropics, became 
an important priority of the WHO’s Diarrhoeal Disease 
Control Programme. Consequently a rotavirus vaccine trial 
became the centrepiece of a series of studies relating to 
rotavirus in The Gambia. These studies are the subject of 
this thesis.
Possible Approaches to Vaccination^
It is clear from the evidence presented above that an 
effective and inexpensive rotavirus vaccine would make a 
considerable contribution to the control of severe 
diarrhoeal disease in the Third World. In industrialised 
countries, a case can also be argued for rotavirus 
vaccination (17). As evidence accumulated showing the 
importance of rotavirus as a pathogen, so efforts were 
directed increasingly towards the development of an 
effective rotavirus vaccine.
Efforts to develop an effective vaccine have, however, been 
hampered by a number of difficulties. Initially, rotavirus 
could not be cultivated in the laboratory but this problem 
has now been overcome. The second problem was lack of 
information about rotavirus immunology and epidemiology. In 
particular, information was lacking with respect to (a) the 
epidemiological and immunological characteristics of the 
four main rotavirus serotypes; (b) the age, geographical, 
and temporal distribution of rotavirus infections, as well
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as the immunological interactions between the various 
subgroups and serotypes, including the nature and degree of 
cross-protection; and (c) the mechanisms of active immunity.
Despite the lack of these basic facts relating to the
immunology and epidemiology of rotavirus infection, various
groups embarked on the development of rotavirus vaccines 
and a number of promising rotavirus vaccine candidates are 
now at various stages of development. This state of affairs 
has led to criticism from some quarters that the pace of 
vaccine development is outstripping knowledge of the 
disease but, in striving for the goal of an appropriate 
vaccine, it is surely desirable to pursue two parallel
courses simultaneously, that is the further investigation of 
epidemiology and the development of suitable vaccine
candidates. As will be seen in Chapters IV and VI, this 
parallel approach was adopted in our Gambian studies.
The first approach to developing a rotavirus vaccine in 
humans was to use live attenuated human rotaviruses (112). 
The possiblity of using this approach developed from the 
successful cultivation of the Na strain of human rotavirus 
in primary African green monkey kidney cells, following 
prior passages in piglets. This cell culture adapted strain, 
which is a serotype 1 virus, had not gained in virulence
during passage, and there was a suggestion that it had
become attenuated. Following numerous in vitro and in vivo 
safety tests, the strain was administered to 12 adult
volunteers in the U.S.A.. None developed a diarrhoeal
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illness. One-half demonstrated serological evidence of 
infection. Further studies were, however, suspended when it 
was discovered that three volunteers had developed low-level 
elevations of serum transaminase ten days after challenge 
(113,114).
More recently, the successful cultivation of each of the 
four main distinct human rotavirus serotypes has offered 
possibilities for development of a vaccine by conventional 
tissue culture methods employing a cultivable human 
rotavirus strain.
Adaptation of human rotavirus strains to low temperatures
also holds promise as another approach to the development of
an attenuated vaccine. In Japan, a temperature sensitive
strain of human rotavirus serotype 1 was obtained by a step-
o o
wise reduction of cultivation temperature from 37 C to 25 C. 
A serotype 2 virus is undergoing similar studies and both 
are being evaluated for safety in piglets (115).
A second strategy for vaccine development involves the use 
of an animal rotavirus strain that can infect man and 
produce cross-protective immunity without inducing illness. 
Various animal strains including the Nebraska calf diarrhoea 
virus (NCDV), U.K. bovine strain, and the rhesus monkey 
strain are now being considered for this purpose.
Animal experiments had shown that infection of gnotobiotic 
piglets by a single serotype did not confer protection 
against an infection by another serotype, although it did
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confer very good protection on challenge with the homologous 
serotype (116). It was, therefore, slightly surprising when 
it was shown that that a bovine rotavirus candidate (RIT 
4237) seemed to protect colostrum deprived piglets against 
infection by a human rotavirus strain (117). This 
information resulted in a variety of trials in Finland which 
are described in detail in the next section. The apparent 
success of these Finnish trial led directly to the field 
trials of this vaccine in The Gambia.
When our studies began in The Gambia, the bovine U.K. strain 
was at the stage of volunteer studies in U.S.A., while 
progress with the rhesus monkey strain was being hampered by 
febrile reactions in some adult volunteers (118).
The third approach to vaccine development is to produce 
reassortant viruses that take advantage of the 
characteristic of reoviridae to undergo genetic 
reassortment with efficiency during mixed infections in cell 
culture (119,120). Reassortants have now been developed 
between wild-type bovine or rhesus rotaviruses and each of 
the four human serotypes. These viruses show promise as 
potential vaccine candidates but testing is still at a 
relatively early stage (120).
The final approach to developing a suitable vaccine is the 
least well advanced but may in time give the best result. 
This approach employs recombinant DNA technology to clone 
the rotavirus genome. Cloned UNA copies of the rotavirus
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double-stranded KNA genomic segments corresponding to 
subgroup and serotype genes have been isolated and the DNA 
sequences determined (121,122). In time, it may be possible 
to prepare antigenically-reactive peptides by chemical 
synthesis or to incorporate rotavirus genes into appropriate 
live viral or bacterial expression vectors.
With each potential vaccine candidate development has to 
pass through several phases. Once the candidate is 
identified it is tested for immunogenicity, safety and 
efficacy in animals. Next, these same characteristics are 
evaluated in man. For ethical reasons, such studies are 
undertaken in seropositive and then seronegative adult 
volunteers. Once immunogenicity and safety have been 
established in adults, progressively younger groups of 
seropositive and then seronegative children can be studied. 
In contrast to animal and adult human studies, efficacy 
studies in children must be undertaken under natural 
conditions, in which children are not challenged 
experimentally with rotavirus, but rather are evaluated for 
protection against naturally occurring disease.
At the time of writing, only two candidate rotavirus 
vaccines (the attenuated bovine rotavirus vaccine - KIT 
4237, and the rhesus monkey virus vaccine) have reached the 
stage of field trials. Of the two, testing of KIT 4237 is 
furthest advanced.
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and Testing of RIT 4237^
The RIT 4237 vaccine strain is a viral clone obtained from 
high-passage level of the Lincoln isolate of the Nebraska 
calf diarrhoea virus in primary bovine kidney cells (123). 
The virus is subgroup I and has a non-human serotype (124). 
In 1983 Zissis published evidence that colostrum-deprived 
piglets would produce antibody to RIT 4237 either given 
intramuscularly (twice) or once intragastrically and once 
intramuscularly (125). He then went on to show the 
protective effect of these vaccination schedules against two 
strains of human origin, evaluated by artificial challenge.
The virus was then produced in high titre in primary monkey 
kidney cells, which are a suitable substrate for human 
vaccine production (123). Immunogenicity and safety in man 
was then established (126). In adults the vaccine did not 
cause clinical symptoms and a booster response in rotavirus 
serum antibodies was seen in 2/20 subjects. The second group 
of vaccinees consisted of 20 children around two years of 
age. The vaccine did not cause detectable rotavirus 
excretion in the stools and did not produce gastrointestinal 
or constitutional symptoms. It did, however, induce 
seroconversion in 13/19 (68%) of children initially found to 
be seronegative by neutralisation assay (126).
Shortly afterwards RIT 4237 was the subject of a randomised, 
double-blind, placebo controlled trial carried out in 
Tampere, Finland (111). 178 infants aged 8 to 11 months
received one dose of the vaccine at the beginning of the
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epidemic season. The majority of the children were 
seronegative at the time of vaccination. 50% of the 
seronegative vaccine recipients seroconverted and a booster 
response to vaccination was detected in 40% of those 
seropositive at the time of vaccination.
In this study vaccination with RIT 4237 resulted in a 50% 
reduction in rotavirus illness (loose stools or diarrhoea) 
and an 88% reduction in rotavirus-associated diarrhoeal 
episodes of at least 24 hours duration. It was, therefore, 
concluded that RIT 4237 gave better protection against 
severe rotavirus disease (defined as symptoms lasting for 
more than 24 hours) than rotavirus infection. It should be 
noted that mild episodes lasting less than 24 hours were 
more common than severe cases although, from a clinical 
viewpoint, the latter were more important.
Another significant and encouraging observation made in the 
course of this trial was that, while RIT 4237 was produced 
from a subgroup I rotavirus, the naturally occurring 
infection was caused by a subgroup II rotavirus. This 
supported the probability of heterologous protection. It 
would have been even more encouraging if the ability to 
protect against a wide variety of serotypes had also been 
demonstrated but at that stage the serotype of the virus 
which caused the outbreak in Finland was not determined.
At the same location the following year clinical efficacy 
was again measured in a larger cohort of 331 infants aged 6
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to 12 months (127). On this occasion, however, two doses of 
vaccine were administered before the epidemic. 
Seroconversion was 53% and the clinical protection rate was 
82% using a similar definition of clinically significant 
rotavirus diarrhoea. The epidemic on this occasion was 
caused by a subgroup II serotype 1 rotavirus, but protection 
was also evident against the small minority of cases caused 
by serotype 2 and 3 viruses.
These children were followed through a second rotavirus 
epidemic and, although the number of cases were small (1 in 
the vaccinated group and 6 in the control group), there was 
evidence that RIT 4237 could protect children through a 
second epidemic season.
When our studies in The Gambia began only the first of the 
Finnish trials had been completed but it is now clear that 
the second study had essentially similar results.
Another important fact which emerged from the Finnish 
studies was that the vaccine "take" could be enhanced, if it 
was administered with an antacid substance like milk (128). 
The presumed explanation for this is that rotavirus is 
sensitive to gastric acidity. Comparisons were made of 
vaccine response in breast-fed and bottle-fed infants. 
Although the response to the vaccine in bottle-fed children 
(86% serconversion) was better than in breast-fed children 
(71% seroconversion), both response rates were considered 
satisfactory. The amount of anti-rotavirus antibody in the 
breast milk was not measured and it is still not clear
48
whether breast milk antibody can compromise vaccination 
"take".
In response to these promising trials conducted in Finland, 
W.H.O. sponsored two further studies of KIT 4237 in the 
developing world, one in Peru and the other in The Gambia.
Study Aims in The Gambia^ .
The major objective of the studies we carried out in The 
Gambia was to find effective ways of controlling rotavirus 
diarrhoea. This could only be achieved by coming to a more 
complete understanding of several related issues. These 
were:
1. The epidemiology of rotavirus in The Gambia. One of the 
main aims of my study was to increase understanding of the 
epidemiology of rotavirus in The Gambia as this information 
would be used to determine future rotavirus vaccination 
policy.
2. The social and environmental context of rotavirus 
disease. I wanted to understand the social and environmental 
context in which rotavirus infection occurred as very little 
was known about this aspect of rotavirus infection in the 
developing world but such information might lead in time to 
effective envionmental interventions.
3. Prevention of rotavirus disease by vaccination. The 
central aim of my research was to assess the protective
49
effect provided by the bovine rotavirus vaccine KIT 4237 in 
a Gambian environment.
4. To investigate vaccine compliance in the rapidly 
expanding urban areas of The Gambia since this knowledge 
would be relevant to any future vaccination policy.
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CHAPTER II
THE GAMBIA AND THE COMMUNITY
Geography^
The Gambia is a small country on the west coast of Africa.
/ // / //
It lies between latitudes 13 3 and 13 49 N and longitudes 
/ // / //
16 48 and 13 47 W (fig. 4.). The country is made up of
two narrow strips of land on either side of the Gambia
river, after which the country is named. The short Atlantic
coastline is only 48kms long while the eastern extremity of
the country is 487kms from the coast, giving a total land
area of 11,607 square kms, making it one of the smallest
countries in Africa. The entire country is low-lying,
nowhere rising more than 90 metres above sea level.
Historically, the Gambia was of interest to various colonial
powers because the river was one of the best natural 
waterways on the west coast of Africa which was a major
centre for trafficking in slaves. The river was disputed by 
the Portuguese, French and British in turn and the somewhat 
strange shape of the country stems from the fact that the 
British declared the area on either side of the river a 
British colony, thereby forming an enclave within Senegal 
which was at that time part of French Nest Africa.
The river is, therefore, the major geographical feature of 
the country, providing as it does a natural means of
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communication and transport. In its non-saline upper
reaches, it provides a source of fresh water for rice
irrigation. Nearer the coast the river becomes salty and low 
lying swamps are found on either side beyond which lies a 
low sandstone plateau with laterite outcrops.
The vegetation is a mixture of savanna grass- and wood-land, 
with the exception of the mangrove swamps which line the
lower reaches of the river.
Since independence was gained in 1965 The Gambia has been a 
parliamentary democracy. The country has six administrative 
divisions but villages have retained their traditional 
political organization with village leaders (Alkalos) and
elders.
C l_i_mate
The Gambia has a tropical climate, with wet and dry seasons
(129). The entire annual rainfall (average 800 mm per year)
occurs within the rainy season which starts in June and
continues till September or October. Towards the end of the
rainy season rainfall decreases while humidity stays high,
but, by the beginning of December, there is a marked fall in
o
humidity and a slight fall in mean temperature ( 26 C in the
o
wet season and 24 C in the dry season ). As will be argued 
later in the text, this change in climate may well have a 
profound influence on the epidemiology of rotavirus in The 
Gambia. Inland, the moderating influence of the sea is not 
felt and variation in temperature is more extreme. The
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climate remains dry until the return of the rains the 
following June but temperatures do tend to rise as the next 
rainy season approaches. The rotavirus epidemic season 
(December - February) is, therefore, associated with 
relatively cool and dry weather.
In common with all of sub-Saharan Africa, The Gambia has 
suffered from a series of poor rainy seasons over the past 
10 - 20 years. This change in rainfall has had a severe
impact on the water table level and has decreased the amount 
of swampland suitable for rice cultivation.
PQ.RU L&Il LOR.
A national census was carried out in 1973 and again in 1983, 
but results are not yet available from the most recent 
census (130). In 1973 the country had a population of 
493,499, giving a population density of 47 per square 
kilometer, making it one of the most densely populated 
countries in the African continent. Unofficial results from 
the 1983 census indicate an annual growth rate of 
approximately 2.5%, with a continuing trend towards rural - 
urban population drift.
In 1973 the infant mortality rate was 217 deaths per 1,000 
live births, making it one of the highest in Africa, matched 
only by Chad, Upper Volta and Mali (131). By 1983 the infant 
mortality rate had fallen to 160 deaths per 1,000 live 
births but this still compares unfavourably with most other
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African rates. The second year mortality rate is also 
relatively high with 41 deaths per 1,000 surviving infants. 
These high rates are reflected in the life expectancy figure 
which was last calculated as 41 years (132).
The largest ethnic group in The Gambia are the Mandinka, who 
comprise over 40% of the total population. The remainder is 
made up of a number of ethnic groups, the largest of which 
are the Fula (18%) and the Wolof (16%). Over 90% of the 
population are Muslim, while a small minority are Christian 
or follow a traditional religion.
Economy.
The majority of the population live in rural areas, growing 
rice, maize, sorghum and millet for their own consumption, 
and groundnuts for export. There is no manufacturing
industry and the groundnut crop is the country’s main source
of foreign currency. The salaried sector is extremely small, 
but a large number of people make their living through
trade, largely operating outside the formal economy. Tourism 
is limited to the coastal region and makes a small
contribution to the economy. In the peri-urban areas around 
the capital Banjul, a larger proportion of the population 
are wage-earners but, even in these circumstances, family 
income is often supplemented by agriculture or trading.
Educat i_on ^
Government efforts have been concentrated on providing
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universal primary education which is provided free for 
children aged eight years or above. Places in the secondary 
schools are awarded on a competitive basis, and an estimated 
40% of those completing primary school go on to secondary 
education.
Health Services^
Public health care in The Gambia is the responsibility of 
The Ministry of Health and Social Welfare. It is provided 
free of charge to all children but some adults are charged 
for consultation and treatment. Health services are provided 
at four levels: (i) sub-dispensaries; (ii) dispensaries;
(iii) health centres; and (iv) hospitals. In 1980, the 
Gambian Primary Health Care Action Plan was implemented 
which has resulted in village health services being 
established in 230 villages with populations greater than 
400 people (133). It is estimated that over 90% of the 
population now have access to basic health services, and the 
country has achieved an enviable level of vaccination 
coverage ( 133).
Administration and delivery of maternal-child health 
services vary between the urban and rural areas. This aspect 
of health care is dealt with in more detail in Chapter VII.
In addition to the medical facilities provided by the 
government, a variety of non-western, traditional forms of 
prevention and treatment are widely available. Many people
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use a combination of traditional and western medicine, often 
selected in a seemingly haphazard manner.
Despite the undoubted success of many aspects of health care 
in The Gambia, the population, in particular children, bear 
a heavy burden of morbidity and mortality. In children, 
malaria, lower respiratory tract infection, malnutrition, 
and diarrhoeal disease are the major problems. In addition 
measles, tuberculosis, schistosomiasis, glomerulonephritis 
and a large variety of skin infections are seen commonly. 
Adults continue to suffer from malaria but most are semi- 
immune. Respiratory infections, venereal disease, 
tuberculosis and hepatoma are among the major diseases which 
cause adults to present to the Medical Research Council 
clinic (134,135).
Bakau^
Bakau is a peri-urban community situated on the coast within 
15 kms of the capital Banjul (fig. 5). The population of 
Bakau have co-operated with various M.R.C. studies since 
1981, and it was the site of all the studies described in 
this thesis.
The first settlers in Bakau were three Mandinka families who 
moved to the area in the late eighteenth century (136) and 
their descendants still hold dominant positions within the 
village hierarchy. In recent years there has been a 
considerable increase in the population of Bakau, as rural 
people have moved to the urban areas seeking employment.
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FIGURE 5
Bakau and other settlements near to Banjul.
Bakau
BANJUL
other urban areas
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Despite this, the community has retained many of the 
features of a traditional village.
The population at the time of the study was approximately 
14,000. A full census of the area was made by the M.R.C. in 
1981 and I updated and extended the census in 1984 for our 
own purposes. A proportion of the population commute each 
day to the capital, where most administrative, commercial 
and industrial work is concentrated. Bakau is itself a 
commercial centre, although all enterprises are on a very 
small scale. In addition, many of the women grow their own 
vegetables in small plots for sale in the market. Income is 
difficult to estimate accurately. Although all families are 
poor by western standards there is little doubt that the 
people of Bakau enjoy a higher living standard than their 
rural counterparts.
Residents of Bakau, when asked where they lived, always 
referred, not to their house, but to the compound in which 
their house was situated. Compounds are spatially discrete, 
areas surrounded by makeshift fences. They vary considerably 
in size but usually contain several houses, which open onto 
a common courtyard. Bakau contains a total of 710 compounds, 
the largest of which houses almost 200 residents.
The majority of houses are built with mud bricks, and have 
corrugate iron roofing and cement floors. Housing standards 
do, however, vary considerably from' grass huts to European 
style houses with glass windows.
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A chlorinated water supply runs to a small number of public 
standpipes. Water is collected in clay or plastic containers 
and carried to the homes. Public services are not extensive 
and there is no mains drainage or sewage disposal. 
Consequently, household sullage can cause unpleasant pools 
of stagnant water in some parts of the town. There are a 
number of refuse collection points and a private cleansing 
firm clears these sites every three to four days. The same 
company is responsible for cleaning the two public latrines 
and collecting and emptying night soil from those compounds 
that use pails. The most commonly used sanitation method is 
the pit latrine but very young children are often allowed to 
defaecate on the ground.
The health facilities available to the people of Bakau 
consist of the main government hospital in the capital, the 
Medical Research Council outpatient clinic and ward, 
situated one kilometer from the edge of Bakau, and the Bakau 
Health Centre. The M.R.C. clinic is very popular because it 
offers a wider range of investigative and curative services, 
but all vaccinations and maternal-child health services are 
provided at the health centre. For this reason very young 
children will visit the health centre frequently, but not 
exclusively, during the first year of life.
Before the present study began meetings were held with the 
elders of Bakau to explain the aims of the various trials 
and subsequently each mother gave informed consent. The 
level of cooperation given by the population of Bakau was 
except ional.
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CHAPTER III 
METHODOLOGY
epidemiological AND CLINICAL ASPECTS,
The Role of Field Assistants,
A total of 15 field assistants worked on various aspects of 
these studies. Their major contribution was within the 
community itself, where they administered questionnaires, 
collected stool samples, paid reminder visits, and acted as 
interpreters. In addition, they also acted as interpreters 
and assistants in the clinics. Most of the field assistants 
were recruited in 1984 before the census of Bakau was 
performed and each one was given training in the various 
tasks and skills which they were required to perform. I also 
maintained a system of continuous in-service training so 
that the range of tasks they could be asked to do was 
constantly expanded as the project progressed.
Surveillance of 1984/85 Outbreak,
The method of surveillance employed during the 1984/85 
rotavirus outbreak in Bakau was very different from that of 
the 1985/86 outbreak, described below. Longitudnal 
surveillance had not been established at the onset of the 
1984/85 outbreak, so the epidemic was monitored by a system 
of case finding within the "at risk" age group. I examined 
all children less than three years of age presenting to the 
M.R.C. clinic or the Bakau health centre with diarrhoea
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during December, January and February, Clinical details were 
recorded and a stool sample collected. Stool samples were 
then screened for rotavirus by ELISA, This method of 
surveillance almost certainly failed to detect less severe 
episodes of rotavirus associated diarrhoea, which were 
treated at home by the mothers, but it did allow us to 
gather some information about the timing and duration of the 
epidemic.
Se.iecti.on of Vaccination Study Cohort
All children born in Bakau during 1985 were invited to 
participate in the rotavirus vaccine trial. In the absence 
of rigorous official vital registration, it was necessary 
for field assistants to find and record all new births to 
mothers resident in the study area whether they occurred at 
Bakau health centre, the government hospital or at home. 
Table III shows the total number of births and those 
excluded from the final analysis. Mothers were interviewed 
during the first few days of the child’s life at which time 
the study was explained and informed consent obtained. 
Children who migrated from the study area during the course 
of the study were considered lost to follow-up and have been 
excluded from the analysis of vaccine efficacy but their 
serological results have been included when available. Only 
children who had received a minimum of one vaccination, at 
least one month before the onset of the rotavirus epidemic, 
were included in the final analysis of vaccine efficacy, but 
the one hundred younger children who were excluded because 
their vaccinations occurred around the time of the epidemic
Table III
1985 birth cohort from Bakau: status with respect to
rotavirus vaccine trial.
1985 births 482
Stillbirths 20
Refusals k 15
Neonatal deaths 14
Total recruited 433
Outmigrations 65
Away during epidemic 15
Denominator for cases 351
Children who received at least one dose of rotavirus 
vaccine at least one month before the onset of the epidemic 
and were resident in the study area during the epidemic = 
253,
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were followed through the 1985/86 epidemic and they have 
been included in calculations for attack and incidence 
rates♦
Vacci_n_ati_on Trial! Study Design^
The rotavirus vaccine study was designed to measure the
v/ *
(\ efficacy of RIT 4237 in a Gambian environment and to
demonstrate any mutual interference between the oral 
rotavirus vaccine and oral polio vaccine when both were 
administered together. The latter was important because
delivery cost would be decreased, and compliance increased, 
if both vaccines could be administered together but mutual 
interference would be undesirable for the rotavirus vaccine 
and unacceptable for polio. For this reason the rotavirus 
vaccine schedules were timed to coincide with the Gambia 
Government’s recommended times for polio vaccination (table 
IV).
At recruitment, children were randomly allocated to one of 
three groups (table V). Group A received three doses of oral 
rotavirus and oral polio vaccines, group B three doses of 
oral placebo and oral polio vaccine and group C three doses 
of oral rotavirus and intramuscular (I.M.) polio vaccines. 
Comparison of polio serology in groups A and B would 
indicate any adverse effect on the response to oral polio 
caused by the rotavirus vaccine, while comparison of the 
rotavirus antibody response in groups A and C would reveal 
any detrimental effect on the rotavirus vaccine caused by 
oral polio.
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Table IV
Recommended vaccination timetable for Gambian children at 
the time of the study.
VACCINATION
B.C.G.
First polio and D.P.T. 
Second polio and D.P.T. 
Third Polio and D.P.T.
Measles and Yellow Fever
AGE OF CHILD 
After Birth
10 weeks 
14 weeks 
18 weeks
9 months
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Table V
Group
Vacc ines
Doses
of
Vaccine
Blood
Samples
Rotavirus vaccine trial.
Vaccination: group allocation and timetable.
Group A Group B Group C
Rotavirus Placebo Rotavirus
+ + +
Oral Polio Oral Polio I.M. Polio
10,14,18 10,14,18 10,14,18
weeks weeks weeks
old old old
10,14,22 10,14,22 10,14,22
weeks weeks weeks
old old old
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The vaccinations were administered by a member of the study 
team but incorporated into the Gambia Government’s 
vaccination programme at Bakau health centre. Gambian 
children normally receive vaccines at the ages of ten, 
fourteen, and eighteen weeks but, in the case of defaulters, 
a period of four weeks was always allowed to elapse between 
each vaccination.
Capillary blood samples were taken before the first and 
second vaccinations, and one month after the third 
vaccination. These samples were analysed for polio and 
rotavirus neutralising antibody.
Rotavirus vaccine and placebo preparations were presented in 
identical precoded vials ensuring that the investigators 
remained blind with respect to the randomisation between 
groups A and B. Since group C received killed intramuscular 
polio vaccine it was not possible to remain fully blind with 
respect to this group although, in practice, any given 
child’s group allocation was not known during clinical 
assessment, surveillance or laboratory analysis.
Fi_eId Surveillance^
Surveillance began during the first week of life, at which 
time a stool was collected from each child. Field assistants 
completed morbidity questionnaires on a weekly basis, 
increasing to twice weekly during the rotavirus epidemic 
season (December - February). The weekly morbidity
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questionnaire (RSI - fig. 6 ) and twice weekly questionnaire 
(RS2 - fig. 7) were similar apart from the period of recall 
required by the mother. Mothers were asked standardised 
questions about the child’s diet and symptomatology since 
the previous visit. Her answers were then recorded on the 
RSI or RS2 surveillance form by the field assistant. 
Information was also collected concerning any other symptoms 
the child had suffered, and a rectal temperature was 
recorded. If the child had suffered from diarrhoea since 
the previous visit and had not already submitted a stool 
specimen at the clinic, the field assistant was instructed 
to collect a specimen at that visit. Each form was then 
checked by a more senior member of the study team, after 
which the data was entered into a microcomputer. In this way 
a complete morbidity record for each child in the cohort was 
compiled.
Clinical. Surveillance
We provided a clinical service for the study children in the 
form of a daily clinic held in the health centre, and an out 
of hours service at the M.R.C. ward, situated nearby. 
Whenever a study child presented with an episode of 
diarrhoea, details of weight, length, temperature, 
symptomatology, diagnosis and treatment were recorded on a 
precoded rotavirus study clinical (RC) form, illustrated in 
figure 8 . In this way a full clinical record was made, and a 
stool collected, during most diarrhoea episodes.
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FIGURE 6
R.S.I.
ROTAVIRUS STUDY
Sex:
Health Card No: 
Patient No: 
Date:
Date of last 
questionnaire:
13
19
Name:
D.O.B.
Mother:
Father:
Compound: ..  .
Village:
1. Is the mother the respondee? Yes; No
If No, is the respondee Guardian; Nursemaid; Relative;
Other
2. Was the child with the respondee? Yes; No
If No, was the child Dead; Hospital; Clinic; Visiting: 
Moved away; Other
3. I
1 I
4.
is the child being fed?
Breast Yes; No
Other milk feeds Yes; No
Weaning foods Yes; No
Sharing adult foods Yes; No
Other. Specify Yes; No
Health. Record whether the child has had any of the following 
symptoms during the past week. Use Yes; No; Don't.know
Day of week
1. Diarrhoea 34
2. Vomiting 42
3. Fever •50
4. Fresh cold/upper respiratory 58
5. Chest infection/lower respiratory 66
6. Other 74
7 I I I 111
25
26
27
28
29
30
31
32
33
Today 1 2 3 4 5 6 7
69 P.T.O.
Examine the health card
Has the child had an episode of diarrhoea during 
the last week? Yes; No
Record the child's temperature
Has stool sample been collected? Yes; No 
If Yes, attach Brady No.
Comments:
83
88 89
Field workers signature
R.S.2.
Name:
D.O.B.
Mother:
Father:
Compound:
Village:
Sex:
FIGURE 7 
ROTAVIRUS STUDY
Health Card No:
Patient No:
Date:
Date of last 
questionnaire:
1
7
13
19 [
1. Is the mother the respondee? Yes; No
If No, is the respondee Guardian, Nursemaid; Relative;
Other
2. Was the child with the respondee? Yes; No
If No, was the child Dead; Hospital; Clinic; Visiting; 
Moved away; Other
3. What is the child being fed?
Health. Record whether the child has had any of the following 
symptoms during the past week. Use Yes; No; Don't know
25
26
27
28
Breast \ Yes; No 29 |
Other milk feeds Yes; No 30
Weaning foods Yes; No 31 |
Sharing adult foods Yes; No 32 |
Other. Specify Yes; No 33
Day of week
1. Diarrhoea 34
2. Vomiting 39
3. Fever 44
4. Fresh cold/upper respiratory 49
5. Chest infection/lower respiratory 54
6. Other 59
Today 1 2 3 4
■
70 P.T.O.
R.S.2.
5. Examine the health card.
Has the child had an episode of diarrhoea recorded during 
the last week? Yes; No
6. Record the child's temperature
7. Has stool sample been collected? Yes; No 
If Yes, attach Brady No. 70
65
71
6 !
8. Comments
Field Worker's signature 75
\
FIGURE 8
ROTAVIRUS STUDY R.C.
Name-'
D.O.B.
Mother: - 
Father: -
Compound: 
Village?
Anthroos
HISTORY
Diarrhoea
SEX:
Health Card No: I 
Patient No: 7
Date: 13
Called: Yes/No
J L
Weight kg: 
Length mm: 
•Temperature °C:
Duration:
Frequency:
Character:
Duration:
Frequency:
Duration
Duration
Vomiting
Fever 
URTI 
Other
Examination
Dehydration. 1.0-5%; 2/5-10%; 3. 10Z and over
Other 
Investigations
1. Stool ’ Brady No.
2. Blood Brady No. 
Severity
20
25
29
48 j____[ 49 [
53 |___ | 54
i _ L
J___L
J _ J
33
35
37
39
41
43
45
LL_l
58
71
F.T.O.
Diagnosis.
Treatment
Has R..C. fori& been completed for an earl :.er .presentation 
of this illness? Yes/No
On what catc was that form completed? 77
76 !__ !
Clinician: 83
A vaccination clinic was held weekly and mothers were paid a 
reminder call when vaccination or blood sampling was due.
Measurements^.
Anthropometric data (weight and length) were also collected 
from each child at the ages of 10,14,22,30,39,65,and 78 
weeks. In addition, the child’s weight was measured whenever 
the presenting complaint was diarrhoea. These data were 
recorded on the child’s own clinical record, but a separate 
computerised record was also kept. From these data it was 
possible to compare the weight and pattern of growth before 
and after clinical episodes of diarrhoea.
For clarity, the timetable of events for a child born on 1st 
January 1985 and followed till April 1986 is shown in figure
9-
Diarrhoea was defined as the passage of three or more loose
stools in any 24 hour period but for children less than two
months of age any change in stool consistency of concern to
the mother was included. Following W.H.O. recommendations, a
case was considered severe if its duration was greater than
24 hours and associated with one or more of the following:
passage of six or more stools in 24 hours, vomiting, rectal
o
temperature > 38 C, clinical dehydration. Using these
criteria almost all the cases examined at the clinic were 
defined as severe. A more sensitive means of assessing 
severity was therefore devised. This method was based on the
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FIGURE 9
Timetable of trial events for a child born on 01.01.85 and 
followed till 30.03.86.
B V V V **:*:* ******
J F M A M J J A S O N D J F  M
A A A
s s s
A A
w w w w w w w w
[---------------- SURVEILLANCE---------------------------->
<-------------------  1985  X --- 1986
B - Birth 
V - Vaccination 
S - Blood sampling 
W - Weight and length 
**** - Epidemic of rotavirus
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TABLE VI
Severity score for clinical features of diarrhoea*
Score
1 2 3
Symptom
Diarrhoea 3 - 4  5 - 8  > 8
frequency
Vomiting 1 - 3  4 - 6  > 6
frequency
Dehydration < 5 %  5 - 10% > 10%
o o o  o
Pyrexia (rectal) < 38 C 38 C to 39 C > 39 C
The total score is calculated by summing the individual 
scores for each symptom*
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total of scores awarded for stool frequency, vomiting 
frequency, degree of dehydration, and level of pyrexia, 
having allocated individual scores according to the system 
illustrated in table VI*
Micro-Computer Management of the Vaccine Tr i_al *_
Computerised data processing was highly desirable because 
of the relatively large amount of data being generated by 
the trial* Similarly, it was necessary to incorporate day- 
to-day management of the trial within the overall data 
system, rather than dealing with the data on a purely 
retrospective basis since the management of age-related 
events longitudinally in the continuously recruited cohort 
would otherwise have been very complex* In The Gambia 
mainframe and large mini computers are not a realistic 
proposition (137) so there was clearly a need to devise a 
suitable microcomputer based system*
Torch Computer’s enhancement of the BBC microcomputer was 
used in conjunction with the dBase II database management 
system, running under the CP/M operating system*
During 1984 field assistants updated the Bakau census* Each 
person within Bakau was then given a six-digit 
identification number, made up of three digits relating to 
the compound of residence and three digits as a personal 
identifier within the compound* These data were then entered 
into a census database. When a new birth was identified the 
next available census number for the appropriate compound
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was then allocated to the infant* From the field assistant’s 
registration of births, records of identification number, 
name, date of birth, sex and field worker assigned to the 
case were compiled for each infant. Thus, the computer 
system was required to accept new subjects in this format on 
an on-going basis throughout the study, together with 
subsequent data relating to vaccinations, anthropometry, 
morbidity and clinic visits.
The system used these data to generate information vital to 
the continued smooth running of the trial. Clinic call lists 
were generated for each weekly vaccination clinic indicating 
which children were due for vaccination, blood sampling and 
anthropometry. The list contained details of each child as 
well as the initials of the field worker responsible for 
each case. Each fieldworker then took a copy of the list, 
identified his or her own cases from it and made home visits 
asking mothers to bring their children to the clinic. Once 
the clinic had been completed, the identification numbers of 
those children who attended were entered into the computer. 
In this way defaulters were automatically identified and 
called for the following week’s clinic, while those who 
attended were recalled at the appropriate time for the next 
stage of the trial. The inter-relationships of these 
requirements are shown conceptually in figure 10.
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FIRURE 10 
Conceptual Data System.
clinical
records
clinic 
call lists
anthropometry
records
COMPUTBR
vaccination
records
cohort lists 
and reports
birth
registrations
inorb idi ty 
questionnaires
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Cross-Sectignal Studies^
Cross-sectional studies were undertaken to determine the 
point prevalence of rotavirus infection (symptomatic and 
asymptomatic) among the vaccine study cohort during the wet 
season (July 1985) and the dry season (January 1986). These 
surveys were extended to include a random sample of older 
Bakau children up to the age of 5 years. Diarrhoea morbidity 
data and a stool sample were collected from each of these 
ch ildren.
Surveillance for Vaccination Side Effects..
Morbidity data were collected daily for a seven day period 
to detect adverse reactions to rotavirus vaccination from a 
subset of 164 children following 164 vaccinations. Rectal 
temperatures were recorded at each visit to detect any 
febrile reaction to vaccination.
Post-Vaccination Vaccine Virus Excretion Surveillance^
An attempt was made to collect a stool sample each day for 
seven days following vaccination to detect evidence of post­
vaccination excretion of the vaccine virus. The visit for 
this purpose coincided with the visit for vaccination side 
effects surveillance.
Social and Environmental Risk Factors
A . search was made for any relationship between social and
78
environmental variables within Bakau and the risk of 
rotavirus associated diarrhoea. 92 children who suffered a 
proven clinical episodes of rotavirus associated diarrhoea 
during the 1985/86 epidemic and 92 controls, who had not 
suffered a clinical rotavirus infection, were investigated. 
Controls were strictly matched for age, sex and rotavirus 
vaccination status. A pre-tested questionnaire (Appendix I) 
was used which sought information on 55 social and 
environmental variables under the broad headings of child’s 
compound, child’s house, water supply, sanitation, hygiene, 
animal contacts, ethnic and family background, parental 
education, family wealth and income, and the child’s feeding 
pattern. The questionnaire was administered to the child’s 
mother with the aid of a Gambian interpreter. Although it 
was not possible to be strictly blind with respect to the 
case/control allocation of each child, in practice the 
status of any given child was not known at the time of the 
interview.
The information was then entered on to the pre-coded 
questionnaire and the paired case/control responses analysed 
using conventional statistical techniques.
Vaccinatj.on Compliance Study^
During August 1985, I collected vaccination compliance data 
retrospectively for 154 children aged 12 - 18 months living 
in Bakau. The vaccination record was copied from the "road 
to health card" which was kept by the mother and contained a
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record of the child’s weight gain, vaccination dates, clinic 
attendances and clinical records* The vaccination status of 
each child, as it had been on its first birthday, was then 
determined. A Gambian child should, have received 9 
vaccinations (table IV) by the age of one, so a score of 0 - 
9 was calculated for each child reflecting the number of 
vaccinations received. The children were then ranked 
according to their vaccination score and two groups selected 
for further investigation. The first group contained 42 
children who were fully immunised and so had scores of 9, 
while the second was made up of 23 poorly immunised 
children with scores of 5 or less. Data on 29 socioeconomic 
and attitudinal variables were collected by means of a pre­
tested questionnaire which was administered to the 
children’s mothers by a Gambian investigator who remained 
blind to the child’s vaccination status (Appendix II).
Ethical_ Approval._
Each separate aspect of this project was passed by the joint 
Gambian Government/Medical Research Council Ethical
Committee which acts as the national ethical committee and 
includes Gambian lay and professional representatives.
LABORATORY METHODS^
The assays used were approved by the Diarrhoeal Disease 
Research Committee of the World Health Organisation. Dr. 
Ruth Bishop visited our laboratories as a W.H.O. consultant 
and, in consultation with Dr. Hilton Whittle the Deputy
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Director of the M.R.C. in The Gambia, decided on the 
methodologies used. The laboratory work was performed by Mr. 
0. Jobe, Miss H. Sillah and Miss F. Shenton although I was 
involved in, and assisted with, these tests throughout the 
period of evaluation. The rotavirus ELISA is a well 
established technique, kits for which were supplied by Dr. 
T. Flewett of the W.H.O. rotavirus reference laboratory in 
Birmingham. The methodology for the rotavirus neutralising 
assay was supplied to Dr. Whittle by Dr. Bishop. The polio 
neutralising antibody assay had been used by Dr. Whittle in 
)( The Gambia for several years and employed standard 
techniques. R.N.A. electrophoresis was carried out by Dr. 
Ray Sanders of the W.H.O. reference laboratory in Birmingham 
who visited The Gambia as a W.H.O. consultant.
Y&cc inat j.on and Placebo Preparations^
„ Rotavirus vaccine RIT 4237 came in monodose vials from the
manufacturer Smith - Kline - RIT. The vaccine lot used in
7.8
this trial (L1207) had a high titre 10 per monodose vial.
The placebo preparation was made from uninfected primary
monkey kidney cells. Both vaccine and placebo were freeze
o
dried and stored at -20 C. In the case of groups A and B 
each vial was reconstituted before use with 0.5ml of oral 
polio vaccine, while 0.5ml of distilled water was used in 
group C. Reconstituted vaccine was then administered orally 
via a tuberculin syringe from which the needle had been 
removed. As the antibody response to rotavirus vaccination 
is enhanced by giving an antacid substance like milk with
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the vaccine (128), mothers were encouraged to continue their 
normal habit of breast feeding their children immediately 
before and after vaccination. Oral Sabin polio vaccine and 
intramuscular Salk vaccine were also supplied in monodose 
vials by the manufacturer of the rotavirus vaccine Smith - 
Kline - KIT.
Laboratory Methods - Detection of Rotavirus in. Stool._
All stools collected were examined for rotavirus using the 
W.H.O. double sandwich ELISA (87). This method required a
10% suspension of faeces in phosphate buffered saline which 
was clarified by low speed centrifugation (3,000g for 10 
15 minutes). The supernatant was then removed and this 
formed the 1/10 dilution which was used for the ELISA 
test. The deposit was discarded.
A 1/10,000 dilution of buffered hyperimmune rabbit serum was
prepared and 0. 1ml of this preparation dispensed into each
well of a microtitre plate. The plate was then covered and
o o
incubated at either 37 C for 2 hours or overnight at 4 C.
The contents of the wells were then discarded and the plates
washed" six times in buffer. 0.075ml of phosphate buffered
saline (PBS) with 0.1% v/v Tween 20 and 0.01M
Ethylenediaminetetraacetic acid (EDTA) pH 7.2 was then added
to each well with the exception of the 2 pairs of plate
control wells.
Two wells were used per faecal sample. 0.025ml of faecal 
extract was added to each of the two wells while the last
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four wells on the plate received substrate only (two wells)
and conjugate and substrate (two wells). These four wells
functioned as ELISA plate controls. The plates were then
o
covered and incubated overnight at 4 C. The microtitre 
plate was then washed six times with PBS. A 0.075 ml volume 
of PBS with 0.1% v/v Tween 20 and 0.01 M EDTA was then added 
to all wells except the four plate control wells. Three 
wells were reserved for the addition of (i) rotavirus 
negative faecal extract (negative control) (ii) rotavirus 
positive control (iii) 1/10 dilution of the rotavirus 
positive control in PBS/EDTA.
0.1ml of 1/10,000 (in PBS/T/BSA) hyperimmune guinea-pig
anti-rotavirus serum was added to each well of the plate
(excluding the plate control wells). The plate was again
o
covered and incubated at 37 C for 2 - 3 hours. The
contents of the wells were discarded after which the plate
was washed in PBS. A 0.1ml volume of alkaline phosphatase
conjugated anti-guinea-pig IgG (diluted 1:500 in PBS/T/BSA)
was then dispensed into each well, including two plate
control wells, after which the plate was covered and
o
incubated for a further 2 hours at 37 C. The conjugate was
then discarded and, after washing with PBS, 0.1ml of
substrate was added to each well (including the two pairs of
plate control wells) and the plate again incubated for
o
approximately 20 minutes at 37 C. The reaction was stopped 
by the addition of 0.05ml of 3 molar sodium hydroxide when 
the 1/10 dilution positive control showed yellow 
colouration. The results could easily be read by eye but a
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more accurate measure was obtained by light absorbence at 
405 nanometres in an automated photometer,
A direct blocking assay was then used to confirm that
positive results were due to specific binding of rotavirus
antibody to rotavirus antigen in the faecal extract. Each
faecal sample requiring confirmation was then incubated 
o
overnight at 4 C with pre-immune rabbit serum and a hyper­
immune rabbit anti-rotavirus serum in separate wells and the 
test repeated as before. Immunological binding with hyper­
immune serum prevented antigenic binding to the solid phase 
resulting in a negative reaction. In the well with pre- 
immune serum no rotavirus blocking took place and the 
antigenic binding to the solid phase took place with a 
positive reaction as previously seen. The optical density of 
true positives incubated with post-immune serum showed at 
least a 50% reduction compared with wells incubated with 
pre-immune serum.
Laboratory Methods - Electrophoreses^
Where possible, positive stool samples had their rotavirus 
R.N.A. electropherotype determined using an adaptation of a 
silver staining polyacramide gel technique (138). A minority 
of ELISA positive samples had insufficient volume of stool 
present in the pot to allow this test to be carried out.
R.N.A. was first extracted from the faecal samples. A 
suspension of faecal sample was prepared in distilled water 
at a concentration of 10 - 20% (wt/vol). A 0.45ml volume of
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suspension was added to 0.05ml of 1 H sodium acetate, pH
5.0, containing 1% sodium dodecyl sulphate (SDS). The
suspension was mixed for a few seconds and then incubated at 
o
37 C for 15 minutes. A 0.5 ml volume of a 3:2 (vol/vol)
phenol - chloroform mixture was added to the faecal
o
suspension, mixed for 30 seconds and then incubated at 56 C 
for a further 15 minutes (Phenol consisted of a mixture of 
500g phenol, 70g m-cresol and 200g of water containing 0.5g
8-hydroxyquino1ine). The emulsified mixture was then
fX centrifuged for 3 minutes in an Epjbndorf centrifuge (model
5412) at l,500g, and the resulting upper aqueous layer
removed, carefully avoiding the intermediate white layer.
E.N.A. was precipitated from the aqueous layer by the
addition of one-tenth volume of 3 H sodium acetate and two
o
volumes of cold ethanol. After incubation at - 20 C for 2
hours the E.N.A. was then pelleted and dried and finally
resuspended in buffer consisting of 0.125 M Tris-HCl pH 6 .8 , 
10% glycerol, and 0.1% bromophenol blue. After 
centrifugation for 3 minutes at 1,500xg for 3 minutes the 
supernatant was used for electrophoresis.
Samples (0.025 mis) were then loaded on to 10% 
polyacrylamide slab gels. Electrophoresis was performed at 
room temperature for 5 hours at 40 mA. E.N.A. visualisation 
was obtained by silver staining according to Herring et al. 
(138). Gels were photographed by illumination from below 
using Polaroid MP.4 land camera, and Polaroid type 667 black 
and white film.
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Laboratory Methods - Rotav_irus Neutra_lj.si.ng Antibody^
Rotavirus neutralising antibody was measured using a
standard technique except that, in our case, we used the
RIT 4237 strain of rotavirus as test antigen. This vaccine
strain was cultivated in HA 104 monkey kidney cells and live
virus was harvested in 1ml aliquots when required for the
neutralising assay. Microtitre plates were then prepared by
5
adding 0.2ml of media containing 2 x 10 MA 104 cells/ml to
o
each well, and incubating at 37 C in a CO incubator for
2
three days, by which time a confluent monolayer of cells had 
formed on each well.
Individual serum samples were then diluted on a separate
microtitre plate starting with a dilution of 1:10 and
progressing through doubling dilutions to 1:1280. The 1ml
aliquot containing rotavirus at 10,000 T.C.I.D. was then
50
diluted 1:100 with minimum essential medium and 0.2ml added
to each serum dilution. Positive control wells, containing
virus and media only, and negative control wells containing
serum and media only were also prepared. The neutralisation
o
plates were then incubated at 37 C for 16 -18 hours in a CO
2
incubator.
The MA 104 cells were then added to the neutralisation
plates, each sample being tested twice in parallel. In
addition each test plate contained a positive and negative
control. Known standards were also included after every five
o
samples. The plates were then incubated for 20 hours at 37 C
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in a CO incubator, at which time culture medium was removed 
2
and the cells fixed with formalin,
Cytopathic effect was then detected by indirect 
immunofluorescence, Rabbit anti-rotavirus antibody was added 
to each well and the plates incubated for 45 minutes. After 
washing with PBS, conjugated sheep anti-rabbit IgG was added 
and the plates again incubated for 45 minutes. Cells were 
again washed and then examined under an ultraviolet light 
microscope for fluorescent foci of rotavirus infected cells.
Titres of neutralising antibody were expressed as the last 
dilution of serum to neutralise the virus and thus inhibit 
fluorescence. When a sample, tested twice in parallel, 
showed a discrepant final titre the geometric mean titre was 
calculated.
Methods 3 Polio Neutral is ing Assay._
In this assay doubling dilutions of sera were used to 
neutralise polio virus type 1, type 2 and type 3 at standard 
dilutions. Neat serum was diluted 1:10 with Eagles minimum 
essential medium and each sample was tested twice in 
parallel. Doubling dilutions of each sample were then made 
in each row of a flat bottomed, low evaporation microtitre 
plate. For each polio virus in each batch of sera tested, 
the following were included: (i) the appropriate polio
standard serum (ii) a positive control (i.e. +ve virus and 
-ve serum) and (iii) a negative control (i.e. -ve virus and
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-ve serum). Each strain of polio virus was then diluted from
o
frozen stock with cold medium and kept at 4 C. Dilutions of
virus were as follows: -polio 1, a 1:2 dilution of stock
6
virus with a concentration of 1 x 10 , polio 2 , stock virus
5
with a concentration of 1 x 10 , polio 3, a 1:3 dilution of
5
stock virus with a concentration of 1 x 10 related to 100
T.C.I.D. by earlier evaluations.
50
A 0.05 ml volume of virus dilution was then added to each
well (except for the negative control) on the microtitre
o
plate. The plate was then covered and kept at +4 C
overnight. The following morning vero cells were stripped
with trypsin, washed and suspended in warm medium at a
5
dilution of 2 x 10 cells/ml. A 0.1 ml volume of this cell 
suspension was then added to each well starting with the 
negative control wells, to avoid the danger of splash back.
The plates were then covered and incubated in a 5% CO 
o 2
incubator at 37 C. The plates were examined for cytopathic
effect on the seventh day.
The titre of polio neutralising antibody was taken as the 
last dilution to neutralise the cytopathic effect of the 
virus strain. Each serum sample was tested twice in parallel 
against each polio strain. Where the duplicated test did not 
give identical results the geometric mean of the two titres 
was taken as the final titre. Negative results were 
expressed as any titre < 1:10.
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Laboratory, methods - electron microscopy.,
A pilot study was conducted to explore the possibility of 
sending stool preparations through the post for examination 
by electron microscopy in the United Kingdom. It should be 
stressed that this was a pilot study. Results have only been 
included because they have some relevance to the virological 
background against which these studies were conducted.
Carbon formvar coated copper grids were supplied by Dr. 
David Cubitt. Faecal samples were mixed with phosphotungstic 
acid (with added Amphotericin B) and then placed on the 
copper grids. Excess fluids was blotted off until the grid 
was dry. The grids were then sent by post to Dr. Cubitt at 
the Central Middlesex Hospital in London. 15% of the grids 
were either damaged in transit or poorly prepared but 
results are available for the remaining 296 samples. I used 
samples from the wet and dry season cross sectional surveys. 
It was not possible to examine all these samples so stools 
from children with diarrhoea were selected along with 
control samples which were very roughly matched for age of 
child providing the sample. I also included some other 
samples which had been collected outwith the cross sectional 
survey but were known to be positive for rotavirus when 
tested by ELISA. The latter have been excluded from the 
presentation of results but they did demonstrate a 93% 
correlation between the ELISA results in The Gambia and Dr. 
Cubitt *s E.M. findings. It must be pointed out that the 
majority of samples came from the vaccine trial cohort and 
only a random sample of older children in the community were
sampled so the age distribution is strongly weighted towards 
younger children.
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CHAPTER IV 
ROTAVIRUS EPIDEMIOLOGY IN BAKAU
INTRODUCTION^
In The Gambia research into the epidemiology of rotavirus 
has been in progress since 1982 and the major findings from 
these earlier studies have already been discussed in Chapter 
1 (44, 102). In these earlier studies it was found that
rotavirus gastroenteritis occurred in short, well defined, 
annual winter epidemics which had their maximum impact on 
infants after the age of one month. Sporadic infection was 
also observed in neonates who were often asymptomatic. In 
the two consecutive years studied there was a major change 
in subgroup, serotype and R.N.A. electropherotype of the 
dominant rotavirus. Rotavirus was clearly an important 
pathogen during the dry season but thoughout the rest of the 
year it had no clinical impact on the population. There was 
anecdotal evidence that rotavirus caused a more severe form 
of gastroenteritis than was usually encountered in The 
Gambia but this was clearly a matter which required more 
investigation. It was also important that I should gather as 
much descriptive data concerning rotavirus in The Gambia as 
was possible because this information would be required in 
the future to facilitate rational decision making about the 
value of more widespread use of a rotavirus vaccine.
As described in Chapter III, a variety of techniques were 
employed between 1984-86 to further increase our 
understanding of rotavirus epidemiology in Bakau. These were
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(a) case finding during the 1984/85 outbreak, (b) 
longitudinal surveillance of the 1985 birth cohort, and (c) 
two cross sectional studies of children aged less than five 
years.
RESULTS^
Seasonal
We confirmed the seasonal pattern of rotavirus infection in 
the Gambia, as clearly defined outbreaks of clinical 
rotavirus infection occurred in the cool dry seasons of two 
further successive years.
During the dry season month of January 1985, 33 children
presented with acute diarrhoea associated with rotavirus but 
no cases were detected in either the month before or after 
this outbreak. These cases occurred in children with ages 
ranging from 1 to 24 months, mean 9.7 months.
The 1985/86 outbreak, which occurred during the equivalent 
cool dry season of the following year, was documented more 
fully. The epidemic began in the last week of December 1985 
and lasted seven weeks. A total of 93 cases were detected of 
which 13 occurred in December, 77 in January and 3 in 
February. The attack rate among 115 children who had not 
received rotavirus vaccine was 36%.
As surveillance was confined to children aged less than 1 
year the cases detected had an age range of 1 to 12 months,
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with a mean of 8 .1 months. Sex distribution of cases was 
approximately equal with 49 males and 44 females.
Outside the epidemic period only three clinically mild 
episodes of rotavirus associated diarrhoea were detected in 
the vaccine study cohort. These infections all occurred in 
children aged between 4 and 8 weeks.
Dry Season Cross-Sectionaj. Survey^
A cross-sectional survey of the rotavirus vaccine study 
cohort was conducted during January 1986, a time of high 
rotavirus transmission. A total of 337 samples were 
collected from 351 children aged 0 - 1 2  months (Table VII). 
Of 79 children with diarrhoea, 20 children had rotavirus 
antigen detected in their stool and 14 had an asypmtomatic 
rotavirus infection. 7 were asymptomatic on the day of 
sampling but rotavirus positive because they were in the 
recovery phase of a clinical rotavirus episode which had 
already been detected. Stool samples were also collected 
from 194 of a random sample of 200 children aged 13-60 
months. Of 44 children with diarrhoea, 5 had rotavirus 
detected in their stool sample, while 2 had asymptomatic 
rotavirus infections. All rotavirus associated cases were 
less than 3 years old.
Eain_y Season Cross-Sect ionaJ Study
A similar cross-sectional survey was undertaken during the 
1985 rainy season. 169 samples were collected from 210
Table VII
A. Cross-sectional study conducted during one week in January 
1986 at a time of high rotavirus transmission on a cohort of 
children aged 0 - 1 2  months.
337 stools collected 78% of the cohort.
79 children had diarrhoea - 23%
20 had rotavirus associated diarrhoea - 6%
14 had asymptomatic rotavirus infections - 4%
7 had asymptomatic rotavirus excretion, but were known cases 
in the recovery phase - 2%
B. Cross-sectional study of a random sample of 205 children 
aged 13 - 60 months, conducted during one week in January, 
1986 at a time of high rotavirus transmission.
194 Stools Collected.
44 had diarrhoea - 21%
5 had rotavirus associated diarrhoea - 2.5%
2 had asymptomatic rotavirus associated diarrhoea - 1%
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vaccine study children who were all at that time less than 7 
months old. 26 children were suffering from diarrhoea but 
none had rotavirus detected in their stools. Only 2 
asymptomatic cases were detected, both in children less than 
2 months old. 220 stools were collected at the same time 
from a random sample of 250 children aged 8 - 6 0  months. 46 
children had diarrhoea but rotavirus was not detected in any 
of their stools. Only 1 case of asymptomatic rotavirus 
infection was detected.
Neonatal. Rotavirus Infecti.on._
During 1985 a stool specimen was collected during the first 
week of life from 410 newly born children. The vast 
majority of children were asymptomatic when the sample was 
taken. This single stool specimen was collected on the day 
that the child was recruited to the study so the age (in 
days) of each child on the day of sampling varied according 
to how quickly the new birth had been detected by the field 
assistant. Only 4 (1%) children were found to be excreting 
rotavirus and none were symptomatic.
Electron Microscopic Examination of Stopis^
Some stools collected from children during the wet and dry 
season cross-sectional surveys were sent for examination by 
electron microscopy (tables VIII and IX). Stools from 
children with diarrhoea were selected and matched with an 
equal number of stools from control children who were 
asymptomatic on the day of sampling. The sample was weighted
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Table VIII
Electron microscopic examination of stools collected in the 
wet season (July 1985). Age range of children 0 - 6 0  months 
but sample heavily weighted towards children < 12 months.
Number of children
Ch ildren 
with 
diarrhoea
62
Ch ildren
without
diarrhoea
64
Small round viruses 
(enterovirus)
0
Small round structured 
viruses
0
Coronaviruses 8
Rotavirus 0 0
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Table IX
Results from electron microscopic examination of stools 
collected during the dry season rotavirus epidemic (January 
1986). Age range of children 0 - 6 0  months but the sample 
was heavily weighted towards children < 12 months.
Children Children
with without
diarrhoea diarrhoea
Number of children 95 75
Small round viruses 1 0
(enterovirus)
Coronavirus 0 1
Rotavirus 21 12
Astrovirus 0 2
Coronavirus 0 1
Adenovirus 1 0
Coronavirus + small 0 1
round virus (enterovirus)
Rotavirus + astrovirus 2 0
Rotavirus + coronavirus 0 1
+ adenovirus
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towards children aged less that 12 months and a 
disproportionate number of control samples were lost or 
damaged in transit but tables VIII and IX are of some value 
because they contain the only available data concerning the 
viruses circulating in the community during the wet and dry 
seasons of my study. The large number of rotaviruses found 
in the dry season sample was expected and simply confirms 
the results shown on Table VII but asymptomatic carriage 
rate appears higher here. It is clear that other viruses 
were circulating during the dry season but they were not 
likely to be major pathogens in this study.
Rotavi_rus Sever ity^
To assess severity we devised a system of scoring which is
discussed in Chapter III and summarised in table VI (page
74). The system of severity assessment recommended by W.H.O.
was inadequate because, although it is useful as a means of
standardising severity assessment for international
comparison, almost all the cases in our study fell into the
severe category so that it failed to discriminate between
mildly severe and very severe cases. Episodes of rotavirus
diarrhoea were significantly more severe than episodes of
2
diarrhoea due to all other causes ( X = 86, 6 d.f., p <
0.001) (Table X). 66% of all children who attended the
clinic with diarrhoea had severity scores of 4 or less. To 
achieve such a low score these children typically presented 
with mild diarrhoea which was not associated with vomiting, 
dehydration or pyrexia. In contrast only 31% of all 
rotavirus cases who came to the clinic fell into this very
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Table X
Comparison of severity scores for 81 cases of rotavirus 
diarrhoea with 1018 diarrhoea presentations due to other 
causes.
Severity All Rotavirus
score diarrhoea cases
3 217 21% 5 6%
4 462 45% 20 25%
5 211 21% 17 21%
6 89 9% 24 30%
7 27 3% 10 12%
8 9 1% 2 2%
9 3 <1% 3 4%
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Figure 11
S everity scores, by age, for rotavirus cases ( • )  and cas 
of diarrhoea due to all other causes ( 0 ) .
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mild category. As rotavirus has an age related incidence,
these data were reanalysed allowing for age at presentation,
using a two way analysis of variance. This analysis again
showed rotavirus episodes to be more severe than those due
to other causes (t = 2.95, p < 0.01) (Fig. 11). Rotavirus
diarrhoea was also more commonly associated with dehydration
than other types of diarrhoea. Only 15 out of a total of 926
cases presenting to the clinic had greater than 10%
dehydration, but 8 of these were subsequently found to be
2
rotavirus infections (X = 32.6 1 d.f. p < 0.001).
Post-Jnfeet ion Weight Patterns^
Clinical rotavirus infection was associated with loss of
weight in the post-infection period. Examination of 166
weight charts (85 clinical cases and 81 age and vaccine
status matched controls) showed acute weight loss during or
immediately after the epidemic in 41 cases and 13 controls 
2
(X = 18.1, 1 d.f., p < 0.001). There was, however, no
difference in the pre-infection weights or weight patterns 
of cases and controls. An example of a weight chart from a 
rotavirus case is shown in figure 12.
R^N^A^. Electropherotype^
There was a major change in R.N.A. electropherotype from one 
year to the next. Table XI shows the results of R.N.A. 
electrophoresis for 73 of the rotaviruses detected in cases 
from Bakau during the 1985/86 epidemic. 67/73 (92%) showed a 
short electropherotype (Illustrated in figure 2). Table XI
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Figure 12
Sample weight chart from a child who suffered acute weight 
loss following an episode of rotavirus diarrhoea. The timing 
of the rotavirus episode is marked with an arrow.
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Table XI
Electropherotypes i_n Bakau dur i_ng 1982/86
Analysis of 73 cases of rotavirus occurring in Bakau, Short 
pattern electropherotypes showed minor variations in
migration patterns which were designated Sa, Sb, and Sc.
SHORT ELECTROPHEROTYPES LONG ELECTROPHEROTYPES
Sa Sb Sc La
17 23 27 6
67/73 (92%) of cases had a short electropherotype.
Ej.N^ A_1 electropherotype by epidemic season^ in Bakau^
R.N.A. Electropherotype.
No. Short No. Long
Year
*
1982/83 5 1
*
1983/84 0 8
1984/85 6 22
1985/86 67 6
Note
*
Rowland et ad (44)
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also contains data from 1982 - 86, some of which has been 
published previously (44). Cases from the 1984/85 outbreak 
shared the same long R.N.A. electropherotype as samples 
collected during the previous year but, by 1985/86, a short 
migration pattern predominated. Six samples collected from 
the intervening non epidemic period also showed a 
predominantly short pattern. Other samples collected during 
the 1985/86 outbreak from a community 6 miles away show a 
similar short pattern.
Although these rotaviruses were sent to the W.H.O. reference 
laboratory in Birmingham to be subgrouped and serotyped the 
technique failed because of high levels of alkaline 
phosphatase in the stool samples. It is, however, reasonable 
to assume that the short electropherotypes were subgroup I 
serotype 2 and the long electropherotypes subgroup II 
serotype 1 or 3.
PISCUSSION^.
The very marked seasonal pattern of rotavirus infection has 
now been observed in The Gambia for four consecutive years. 
Epidemics occur during the cool dry season months with the 
most intense transmission in January. During the rest of the 
year rotavirus infection is almost entirely confined to mild 
or asymptomatic infections in neonates and very young 
children. At the end of December or early January, however, 
an epidemic, the onset of which can be accurately pinpointed 
to the day, suddenly begins. At present we can only 
speculate as to the cause of this very striking feature in
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the epidemiology of rotavirus in The Gambia,
In most temperate countries rotavirus infection is endemic 
but more common during the winter months while studies from 
those tropical countries which experience seasonal variation 
show an association between rotavirus infection and cool dry 
weather (26,27,29,31,52,139,140). This is particularly 
striking in a recent study from Gabon (141) where a bimodal 
dry season corresponded to a bimodal epidemic. Some recent 
laboratory studies have suggested a possible mechanism which 
might account for this observation. The Wa strain of human 
rotavirus was found to survive longer on non-porous surfaces 
in conditions of low temperatures and low relative humidity 
(53). Other studies have shown improved survival of a bovine 
rotavirus at low temperatures and either low or very high, 
but not intermediate, humidity (142). There seems to be no 
obvious behavioural factor associated with the seasonal 
nature of rotavirus infection in Bakau so an association 
between rotavirus survival on fomites and environmental 
factors, like temperature and humidity, might be one 
possible explanation for the seasonal pattern which has been 
described.
During the epidemic of 1985/86 transmission was intense, and 
almost completely confined to children less than two years 
of age. The clinical attack rate for infants was 36%, and 
40% of all diarrhoeal episodes in infants presenting to the 
clinic were due to rotavirus. A cross sectional study 
carried out at the height of the epidemic showed that the
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point prevalence of rotavirus associated diarrhoea in
children aged 0 - 1 2  months was 6%, while the survey of
children aged 13 - 60 months showed that clinical infection
was less intense in older children and did not occur beyond 
the age of 36 months.
Hospital studies have shown that in certain circumstances 
the level of asymptomatic rotavirus infection can be very 
high (143). Other studies have now established that 
asymptomatic shedding of rotavirus is common in neonates (54 
- 66) but the evidence from community studies is less 
uniform, with an enormous range of asymptomatic infection
rates reported . In our studies we found a 1% asymptomatic 
neonatal infection rate but this was almost certainly an 
underestimate as only one sample was collected from each 
child during the first week of life. Rotavirus shedding in 
neonates only lasts for approximately 48 hours and can occur 
at any time during the first week or two of life so very 
frequent sampling is required if accurate rates of 
asymptomatic infection are to be determined. The results 
from the non epidemic cross sectional survey suggests that, 
in older children, there is a very low level of asymptomatic 
shedding throughout the year, while the epidemic season 
cross sectional survey suggests that at times of high 
transmission asymptomatic rotavirus shedding is common. On 
the day of sampling the point prevalence of asymptomatic 
shedding was two thirds that of symptomatic infection (4% 
and 6% respectively).
One of the difficulties raised by the high rate of
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asymptomatic infection during the rotavirus epidemic was the 
interpretation of stool ELISA results. During this study I 
limited the analysis of stool specimens to the detection of 
rotavirus. There was, however, always the danger that other 
organisms were causing diarrhoea and rotavirus was present 
in the stool as an asymptomatic passenger. The frequency 
with which this happened would obviously depend on which 
other pathogens were circulating in the community, but it 
should be stressed that the simple detection of rotavirus in 
the stool did not prove that it is causing diarrhoea. In 
this respect the results of the samples sent for E.M. are 
helpful. No firm conclusions can be drawn from such a small 
set of results but there was no evidence that other viruses 
were circulating in significant numbers during the rotavirus 
epidemic and the studies carried out during 1981 - 82 in
Bakau did not show a significant number of mixed 
rotavirus/bacterial infections. When this limited evidence 
is added to the fact that rotavirus associated attacks were 
clinically distinct it is likely that, in the majority of 
cases, clinical episodes of diarrhoea associated with 
rotavirus were caused by this agent.
Data have been collected on the predominant R.N.A. 
electropherotypes responsible for rotavirus outbreaks in 
four successive years in Bakau. Short patterns were observed 
in 1982/83 while in the two successive years long patterns 
predominated. In 1985/86 the patterns were predominantly 
short. Only 5 samples are available from the 1985 wet season 
of which 4 show a short R.N.A. electropherotype similar to
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the pattern found in the rotaviruses which predominated in 
the following epidemic. Although the number of samples in 
some years is small, it does seem that in any single 
epidemic one strain of the virus predominates. In general, 
multiple electropherotypes exist simultaneously in most 
closely populated communities but, usually, one or two 
electropherotypes are dominant in any single outbreak. 
Sometimes the dominant electropherotype is detected in small 
numbers for several months before it becomes dominant. 
Observations will have to be made in subsequent epidemics to 
determine whether the cycle of changing strains which seemed 
to be emerging during 1982 - 86 continues as variations of 
this type might play an important role in determining the 
response to different rotavirus vaccines.
Episodes of rotavirus associated diarrhoea were more severe 
than those due to other causes. I was, however, struck by 
the fact that the vast majority of diarrhoea episodes due 
to all causes were very mild. A child typically presented 
with 3 - 6 loose stools per day and no other symptoms or
signs. Dehydration was uncommon but, when it did occur, the 
majority of cases with significant dehydration were found to 
be associated with rotavirus. Oral rehydration with home 
made sugar salt solution has been promoted energetically in 
Bakau for several years and each child had early access to 
our treatment facilities, therefore, dehydration as the only 
index of severity could have been misleading. To overcome 
this difficulty we devised a scoring system with separate 
scores for frequency of diarrhoea and vomiting, degree of 
dehydration and level of pyrexia (Table VI). Children with
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rotavirus infections who visited the clinic had 
significantly higher severity scores than all other clinic 
cases presenting with diarrhoea with allowance made for age 
at presentation.
The relative severity of rotavirus infection is reflected in 
the fact that the clinical cases showed evidence of acute 
associated weight loss which seemed to persist for some 
weeks after the attack. This potentially important 
phenomenon will require further investigation.
The results reported in this chapter confirm the importance 
of rotavirus as an aetioligical agent of diarrhoea in The 
Gambia. Its importance lies in its severity. The formal data 
reported above was corroborated by the fact that all 14 
children who required admission for rehydration to the small 
M.R.C. children’s ward during January of 1986 had rotavirs 
detected in their stools. The potential benefits of 
vaccination should not, however, be overestimated. If the 
clinical severity of rotavirus infection could be prevented 
by vaccination deaths from acute dehydration would be 
reduced and this, together with the prevention of weight 
loss, would be significant. However, the impact on 
diarrhoeal disease as a whole is likely to be modest.
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CHAPTER V
SOCIAL AMD ENVIRONMENTAL RISK FACTORS FOR ROTAVIRUS DIARRHOEA 
INTRODUCTION^
Throughout the developing world, health planners are 
increasingly coming to realise that effective strategies for 
the control of disease require co-operation among a variety 
of agencies and Government departments. As a consequence, 
the concept of integrated development has increasingly 
become the orthodoxy of the day. The integrated development 
approach seeks to attack problems from several standpoints, 
so that the combined skills of agriculturalists, 
nutritionists, water engineers and doctors might be brought 
to bear on, for example, a project designed to increase the 
nutritional level and food production of a community with a 
high level of childhood marasmus and kwashiorkor. This 
approach has a strong intellectual appeal but in practice it 
has had notable failures as well as successes. Integral to 
this approach has been the need to be sensitive to the 
wishes of those people the project was designed to help. 
Increasing emphasis has been placed on low cost and low 
technology solutions which will be sustained by the 
community once the initial project has come to an end.
These ideas are relevant to any strategy for the control of 
rotavirus in The Gambia. Improved sanitation, housing and 
water supply might make as much of an impact on the disease 
as an effective vaccine, and would have many other
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beneficial effects. Clearly, such measures are not in 
competition with vaccination but any integrated approach to 
disease prevention should employ all effective means. 
Unfortunately, The Gambia is a poor country with many 
problems and limited funds must be spent in the most cost - 
effective way. For that reason we decided to investigate 
particular social and environmental factors within Bakau 
which might be associated with a high risk of rotavirus
infection. If such factors could be discovered, it might
then be possible to intervene in specific and less expensive 
ways to decrease the prevalence of rotavirus disease.
In Europe and North America the reduction of infant and 
child mortality which took place throughout much of last 
century was closely associated with major improvements in 
living conditions. These included the provision of piped 
water, safe sewage disposal, rising standards of housing, 
improved nutrition and universal education. Specific medical 
interventions seem to have played a small part, and largely 
arrived on the scene long after the downward trend in
mortality figures had been established (144). Such 
comprehensive improvements are, however, a long term goal in 
most developing countries. In an attempt to achieve more 
immediate results Governments and aid agencies have often 
tried to focus on single interventions.
Although the provision of safe drinking water and adequate 
sanitation has been stressed in many programmes aimed at
reducing diarrhoeal diseases , the results have often been
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disappointing. Some studies have shown that if mothers are 
given specific health related instruction, such as the
importance of hand washing (145) or information in the 
hygienic use of latrines (146), then health benefits do 
accrue. Other studies have highlighted the value of
education in general (147,148) which seems to have a less
direct but more profound effect on disease. It is, however,
difficult in such studies to avoid the difficulties of 
confounding variables, as those with better education often 
also have higher incomes, smaller families and better homes.
The fact that the incidence rates and attack rates for
rotavirus have been broadly similar, irrespective of the
country in which these statistics have been gathered, 
suggests that environmental factors may be less important in 
determining the prevalence of rotavirus disease than they 
are in diarrhoea caused by other common enteric pathogens.
Despite these potential difficulties, I considered it a 
worthwhile exercise to investigate the social and 
environmental background of 92 cases and an equal number of 
age, and vaccine status matched controls. The variables I
tested for are listed in Appendix I.
RESULTS,
The Child Is Compound - Table. XII._
In Bakau, compounds vary considerably in size and housing
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Table XII
Variables concerning the compounds and dwellings occupied 
by 92 cases of rotavirus diarrhoea and 92 controls.
Compound
CASES CONTROLS
No. of buildings in compound (mean) 3.7 4.6
No. of people in compound (mean) 38 45
No. of children less than 3 years(mean) 5.6 6.8
No. of children less than 2 years(mean) 3.2 3.2
No. of European style houses 7 16
No. of Cement/corrugate house 82 113
No. of Hud/corrugate houses 242 281
No. of Nud/thatch houses 12 12
LweJ._l_ing
CASE CONTROL
No. sharing house (mean) 6.0 7.2
No. eating out of common bowl (mean) 6.6 7.2
No. under three years (mean) 1.6 1.7
No. under two years (mean) 0.9 0.9
No. sharing bedroom (mean) 3.8 2.8
No. sharing bed (mean) 2.8 2.8
No. living in European style house 3 6
No. living in Cement/corrugate house 28 33
No. living in Hud/corrugate house 57 50
No. living in Mud/thatch house 4 3
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type. In the older part of the town, compounds are large 
with nearly every resident related to one-another in some 
way. In the newer parts of the town compounds are ethnically 
more mixed and tend to be smaller. We were, however, unable 
to demonstrate any difference in the average number of
people living in the compound, the average number of
buildings, or the type of buildings. The most popular type 
of dwelling was a simple house with one or two rooms, 
constructed from mud bricks, with a corrugate iron roof. 
Poorer forms of housing (mud walls, with thatch roofing) 
were uncommon but occurred in approximately equal numbers in 
the compounds of cases and controls.
A crude crowding index, calculated by dividing the number of 
compound occupants by the number of houses, showed no
significant difference. As rotavirus is a disease of young 
children, we counted the number of children under the age of 
two and three years respectively living in the compound but 
no significant difference was detected between the groups.
The ChUdls Lwe.LLi.ng - Table XI1^
It might be argued that the particular dwelling occupied by 
the cases or controls was more relevant to the risk of 
disease transmission than the whole compound but we were 
unable to detect any significant difference in housing type 
between cases and controls. The total number of people
sharing the dwelling, the number of people who fed from the 
same bowl of communal food and the number of people sharing 
the child’s bed were not significantly different. The number
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of children less than three years old sharing the house, 
sharing the bedroom and sharing the bed, was also very 
similar in both groups.
Water Supply - Table XI11
Bakau’s chlorinated water supply runs to approximately 40 
communal standpipes. Mothers and older children collect 
water in large plastic, clay or metal containers which are 
then carried to the house and used as a communal source of 
water for the occupants of each house. The usual procedure 
is to have separate containers for washing and drinking 
water but this is not universal.
Me were unable to detect any difference in the average 
distance cases and controls lived from the nearest 
standpipe. There was no significant difference in the type 
of containers used, the frequency with which they were 
refilled, the frequency with which they were cleaned or the 
number of people who used water from them.
Sanitation - Table XIV^
Sanitation in Bakau was provided principally by pit latrines 
but a few compounds used pails while some houses had flush 
toilets. Approximately 10% of compounds were without- any 
sanitation facilities. Very small children were, however, 
frequently allowed to defaecate on the ground the faeces 
then being covered with a little soil. More hygiene­
conscious mothers provided their children with a small pot.
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Table XIII
Water supply and storage for 92 cases and 92 controls.
CASES CONTROLS
Mean distance to standpipe (metres) 76 84
No. storing in clay jars 75 68
No. storing in metal pots 25 33
No. storing in plastic buckets 49 57
No. storing in glass bottles 17 20
No. of people using water (mean) 6.0 6.6
No. of children using water (mean) 1.6 1.3
No. of times/day water collected (mean) 1.7 1.9
No. of times/day containers cleaned(mean)1.6 1.7
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Table XIV
Sanitation facilities and behaviour for 92 cases and 92 
controls,
CASES CONTROLS
No of children using pot 61 64
No. of children using the ground 18 15
No. of children using a nappy 10 12
No. of compounds with a latrine 83 78
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We were not able to detect any difference in the sanitation 
facilities or toilet habits between the compounds of cases 
or controls. Defaecation habits and means of disposal were 
not significantly different for cases or controls.
Hygiene^ Cl.eanliness and Animal Contact - Table XV._
It seemed likely that the mother’s personal hygiene might 
influence disease transmission but there was no significant 
difference in handwashing activity, childcare activities or 
general cleanliness. We asked, in particular, whether a 
study child was allowed to play in the soil outside the 
compound, which seemed a potentially hazardous activity 
because of the danger of contact with faecal material. There 
was no difference in the proportion of children allowed to 
do this.
Mothers were advised to prepare fresh weaning food for the 
child before each meal, but working mothers would often 
prepare food in the morning which was left standing all day. 
There was no difference in the frequency of this behaviour 
between the two groups.
Animals frequently live within the compounds and sometimes 
within the homes. Little is known about the frequency with 
which animal rotaviruses infect humans but animal contact 
is a potential risk factor. There was no significance 
difference between the groups in the number or range of 
animals with which cases and controls had effective contact
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Table XV
Hygiene and cleanliness in 92 cases and 92 controls.
CASES CONTROLS
No. of times swept daily 74 82
Regular hand washing; by mothers 92 92
Prepares fresh food for each
meal for the child 39 32
Prepare s fresh food dai ly 46 53
Prepares fresh food for child
less than daily 7 7
Mean clean1iness/t idyness
score allocated by field assistant
on a 0 - 5 scale 3.3 3.1
Chil d allowed to sit
on the ground 44 45
Chil d eats sand 33 33
Same broom used for
ins ide and outside the house 33 29
No. in contact with cows 0 1
No. in contact with goats 18 26
No. in contact with sheep 50 61
No. in contact with pigs 0 2
No. in contact with dogs 48 31
No. in contact with cats 86 82
No. in contact with ch ickens 90 90
119
except for dogs which were more commonly found in the
compounds of cases. This difference just reached statistical
2
significance (X = 5.7, 1 d.f. p < 0.02). This finding is
difficult to explain and is discussed later. Cows and pigs 
are the most likely source of animal rotaviruses but both 
these animals were uncommon in Bakau as the population is 
Muslim and does not keep pigs while cows are largely
confined to rural areas.
Fam ^l_y Background - Tab^e XVI ^
Although there was considerable diversity in family
structure and ethnic background within Bakau, these factors 
were similar for cases and controls. Ethnicity, marital 
status, and employment status of both parents were similar 
in each group. These results are not surprising because, 
although ethnic stereotypes did exist, there was very little 
ethnic segregation. The vast majority of compounds were
ethnically mixed and over one third of the marriages were
between different racial groups.
No significant differences were detected in family
structure. The mother’s position in the order of wives, the 
number of children she had borne, the number of live
children she had and the number of deaths and stillbirths 
were all similar for cases and controls.
Parental Education and Attitude to Di_sea.se - Table XVII
As discussed earlier in this chapter, parental education 
often correlates with various measures of childhood health
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Table XVI
Family background of 92 cases and 92
CASES
No. of Mandinka mothers 35
No. of Wollof mothers 11
No. of Jolla mothers 23
Other tribal groups 23
No. of Mandinka fathers 39
No. of Wollof fathers 8
No. of Jolla fathers 12
Other tribal groups 13
No. of divorced mothers 0
No. of unmarried mothers 10
No. of married mothers 82
No. of fathers living in compound 68
Mothers in paid employment 17
Mean number of sibs 2.9
No. of sti1lbirths/abortions(mean) 0.3
No. of deaths in sibs (mean) 0.5
contro Is. 
CONTROLS 
42 
8 
14 
14
41
11
8
22
1
9
82
70 
27 
2.9 
0.4 
0. 5
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status. In Bakau, houever, we found that the the number of 
years of formal education and the level of schooling reached 
were similar for both the mothers and fathers of cases and 
controls. We also enquired about their belief with respect 
to the cause of disease. Answers were grouped according to 
whether they represented a more superstitious or more 
scientific view of disease. There was no difference in the
replies given by the mothers of cases and controls.
Parental, Income and Wealth. - Table XVI I_I._
It was not easy to estimate income or wealth in Bakau. The 
father’s occupation was a poor indicator of true wealth, 
while other possible indicators, like housing type, 
ownership of consumer items, were equally unreliable. Having 
a white collar job and a refrigerator were probably more 
indicative of an identification with Western values, than a 
true index of wealth itself. Despite these difficulties, we 
had to make some measure of wealth and so we relied on the
reported combined monthly income, the amount spent per day
on food and the ownership of consumer items. No significant 
differences were detected between the two groups.
Feeding and NutrjLtj.orK
Almost all children in Bakau are exclusively breast-fed for 
the first 3-6 months of life. A weaning food called "pap" is 
then introduced into the diet. This is made from pounded 
grain or rice which is boiled with a little sugar and salt.
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Table XVII
Parental education and attitude to disease in 92 cases and 
92 controls.
CASES CONTROLS
Educat ipru
Years of maternal education(mean) 2.1 1.8
No. of mothers finishing primary 18 17
No. of mothers finishing secondary 11 13
Years of paternal education (mean) 4.4 3.7
No. of fathers finishing primary 11 3
No. of fathers finishing secondary 30 33
Att i_tude to disease
No. of mothers with superstitious
understanding of disease 8 4
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Table XVIII
Parental income and wealth for 92 cases and 92 controls.
CASES CONTPOLS
Mean amount (in Dalasis) spent
on food per person per day 1.6 2.2
Estimated cash income per month (mean) HOOD 785D
No. with paid maid 27 17
No. with cash salary 55 68
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till at the age of 9 - 12 months adult foods are shared with 
the child. Breast feeding usually continues well into the 
second year of life. Although this is the general pattern 
there is a wide variation. We were not, however, able to 
detect any difference in feeding practices of cases and 
controls.
DISCUSSION AND CONCLUSIONS^
This study has shown that the risk of clinical rotavirus 
infection is not strongly associated with social and 
environmental factors. Methodological problems certainly 
existed. Factors like wealth, hygiene, attitudes and 
cleanliness were difficult to define and measure but, 
despite these problems, it is disconcerting that none of the 
measured factors correlated with the risk of clinical 
rotavirus infection.
There have been very few studies published which have looked 
for rotavirus infection risk factors. The only one of any 
consequence (149) found that rotavirus infection on a North 
American Indian reservation was associated with the presence 
of a domestic dog in the household. We also found an 
association between dogs and rotavirus cases. This 
association is not easy to explain as dogs are not known to 
suffer from clinical rotavirus infection but one might 
speculate that they may play a part in transmission of the 
virus as they often lie in faecally contaminated soil and 
have close contact with children. It is also possible that 
the association between dogs and rotavirus cases has arisen
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by chance. This is always a possibility when so many 
variables are being investigated. The study carried out on 
the Indian reservation also associated rotavirus infection 
with a household contacts under the age of two years. It was 
argued that children less than two years old, often being 
in nappies, would also be at high risk of symptomatic and 
asymptomatic rotavirus infection and would, therefore, be
potential sources of infection. Almost all the children in 
our survey had household contacts aged less than two years, 
and the mean number of contacts was approximately 3 in both 
groups. The risk of exposure to other sources of faecal 
contamination was also very high given the sanitation 
facilities available in Bakau. It might, therefore, be 
argued that contact with other very young children and
exposure to faecally contaminated substances were ubiquitous 
risk factors for all Bakau children.
Rotavirus has been detected in the handwashings of
attendants of children with diarrhoea (150), so one might 
have expected standards of hygiene and water storage 
practices to be related to the risk of rotavirus associated 
diarrhoea. We were, however, unable to demonstrate any such 
association.
It must, however, be emphasised that, in this community, 
symptomatic and asymptomatic rotavirus infections are both 
very common during the epidemic season. As stated 
previously, the attack rate in Bakau infants for clinical 
rotavirus infection was 36% and there is evidence to show
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that asymtomatic infection is at least two thirds as common 
as symptomatic infection. Further evidence pointing to the 
high incidence of rotavirus infection in young Gambian 
children comes from unpublished serum surveys which have 
shown that by the age of two years most children have 
antibodies to rotavirus. It is, therefore, possible that 
many of the control children had suffered asymptomatic 
rotavirus infections during the epidemic.
My hypothesis is that, during the rotavirus epidemic period, 
almost all children within the at risk age group in Bakau 
came into contact with the wild virus. Some children 
developed rotavirus associated diarrhoea while others became 
asymptomatic carriers. Host factors, like immune status, 
will have been far more important than environmental factors 
in determining the child’s response to rotavirus. 
Environmental factors will probably have influenced the 
frequency of exposure and the infecting dose of virus but, 
even if this did occur, the effect was not large enough to 
be detected by my methodology.
Improvements in housing, sanitation etc. are clearly 
important for the people of Bakau, but it seems that if they 
come, such improvements are unlikely to have a major impact 
on the burden of rotavirus disease.
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CHAPTER VI
A TRIAL OF ROTAVIRUS VACCINE RIT 4237
in tr od uct io n^
As was discussed in Chapters I and III, we conducted a 
randomised, double blind, placebo controlled trial of the 
attenuated bovine rotavirus vaccine RIT 4237* This part of 
the study had two main aims. Firstly, to measure vaccine 
efficacy and secondly to demonstrate any mutual interference 
between the oral rotavirus vaccine and oral polio vaccine 
when both were administered together.
RESULTS,.
Compliance^
During 1985, 433 children were recruited into the study and
randomly allocated to one of three groups. 80 of these 
children left the study area before follow-up was completed 
and so have been excluded from the analysis of vaccine 
efficacy. 100 children, born in the latter part of the year, 
have been excluded because they received their first vaccine 
within one month of the onset of the epidemic. The remaining 
253 children had received at least one vaccine dose, one 
month or more before the epidemic, and were under 
surveillance for the full duration of the trial.
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1st vac 
2nd vac 
3rd vac 
Fo1low-
Table XIX
Vaccination Compliance
1st call within 1 month
81% 98%
81% 100%
76% 99%
up bleed 74% 99%
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Vaccination compliance was such that almost every child 
received each vaccination within one month of the expected 
date (table XIX) and the majority (80%) on the expected 
date. Of the reported cases of diarrhoea, 86% had stools 
collected and 88% were examined by a clinician and clinical 
records made.
Vaccine Side Effects^
No major vaccine side effects were detected among 248 
infants given one or more doses of rotavirus vaccine. 
Morbidity data was collected for a seven day period after 
164 separate vaccinations on 164 children, comprising 51, 51 
and 52 children respectively from each vaccination group A, 
B and C. There were no significant differences in mean 
temperature or reported symptoms between the groups.
Post-Vacc^nation Eotay_irus Excretion^
There was no apparent post-vaccination excretion of the 
vaccine virus. 276 stools collected from 104 rotavirus 
vaccine recipients during the seven days following 
vaccination were all negative for rotavirus when tested by 
E.L.I.S.A.
Eotavi_rus Neutralising Antibody Levels
Mean neutralising antibody titres to rotavirus were high in 
all groups at the time of first vaccination (table XX). None 
of the children were seronegative. In the controls
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Table XX
Eotavirus neutralising antibody titre before and 1 month 
after the administration of 3 doses of rotavirus vaccine or 
placebo.
Group N
Pre-vacc inat ion
Geometric 95% Cl 
Mean Titre
Post-vacc inat ion
Geometric 95% Cl 
Mean Titre
A 86 138 111-171
(rotavirus and oral polio)
162 127-206
B 91 155 126-190
(placebo and oral polio)
87 73-103
C 99 162 135-194
(rotavirus and killed polio)
162 130-202
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(group B) the mean antibody level fell significantly (paired 
t = 3.96, p < 0.001) between pre- and post-vaccination
samples. In the vaccinated groups, A and C, post-vaccination
i
titres were significantly higher than those of the control
group (t = 4.13, p < 0.001 in both cases). The proportion
of children who showed a rise in titre of one dilution or
more was significantly higher in the vaccinated group
2
(84/185 (45%) ) than in the control group (20/91 (22%)) (X 
= 13.2, 1 d.f., p <0.001) (Table XXI). Only 48/185 (26%) of
vaccinated children boosted their rotavirus antibody titres 
by two or more dilutions. The proportion of children showing 
a rise in titre was higher among those with low pre­
vaccination titre (table XXII) but a similar trend was
observed in controls, suggesting that this may have been 
attributable to regression to the mean. When the mean change 
in log titre was analysed, the effect of vaccination, as 
assessed by the difference between vaccinees and controls, 
was unrelated to pre-vaccination titre.
There was no evidence that the response to rotavirus 
vaccination was compromised by the simultaneous 
administration of oral polio vaccine, for geometric mean
post-vaccination rotavirus antibody levels were identical in 
groups A and C (Table XX).
Vaccj.ne Efficacy^
The distribution within groups of clinical cases of
rotavirus associated diarrhoea, all of which occurred during 
a well demarcated epidemic which began in late December 1985
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and finished in February 1986 (Chapter IV), is shown in
Table XXIII. The proportion of infants who became cases in
the vaccinated groups (A + C) was significantly lower than
2
in the control group (X = 3.95, 1 d.f., p < 0.05) and the
vaccine efficacy was estimated as 33% (95% C.I. 4% to 53%). 
The results were not materially altered when the analysis 
was restricted to children who had received all three doses 
of vaccine one month or more prior to the onset of the 
epidemic.
Vaccination and Sever rty._
The rotavirus vaccine had no effect on the severity of
attacks (table XXIV). Following W.H.O. recommendations a
case was considered severe if the duration of diarrhoea was
greater than 24 hours and if it was associated with one or
more of the following: passage of six or more stools in 24
o
hours, vomiting, rectal temperature > 38 C or clinical
dehydration. By this definition almost all cases which we
examined were severe. Cases which were not brought to the
clinic were probably less severe but, since we have no firm
data on these cases, they have been excluded from analysis.
The proportions of severe cases in the vaccinated (40/43)
and the control groups (21/26) were not significantly 
2
different (X = 1.3, n.s.). Table XXIV shows a comparison of 
mean severity scores (using the scoring system described in 
Chapter IV) between the groups. There was no significant 
difference in mean score between groups.
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Table XXI
Changes in titre of rotavirus neutralising antibody one 
month after the administration of 3 doses of rotavirus 
vacc ine.
1 2 3
INCREASE STATIC DECREASE
38 (44%) 5 (6%) 43 (50%)
oral polio)
B 91 20 (22%) 10 (11%) 61 (67%)
(placebo and oral polio)
C 99 46 (46%) 9 (9%) 44 (45%)
(rotavirus and killed polio)
A + C 185 84 (45%) 14 (8%) 87 (47%)
(combined rotavirus vaccine groups)
notes
1. Post-vaccination titre one or more dilutions higher than 
pr e-vacc in at ion.
2. Post-vaccination titre same dilution as pre-vaccination.
3. Post-vaccination titre one or more dilutions lower than 
pre-vacc inat ion.
GROUP N
A 86
(rotavirus and
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Table XXII
Relationship between pre-vaccination rotavirus neutralising 
antibody level and subsequent serological response to 
vacc inat ion.
Pre-vaccination 
t i tre
Number showing increase:Mean change in titre 
in titre :■
<80 
80 or 112 
160 or 224 
> 224
Total
Vaccinees Controls 
35/41(85%) 9/17(53%)
23/38(61%) 9/28(32%)
18/53(34%) 2/18(11%)
8/53(15%) 0/28(0%)
84/185(45%) 20/91(22%)
Vaccinees Controls Diff 
+0.603 +0.310 0.293
+0.233 -0.097 0.330
-0.082 -0.302 0.220
-0.456 -0.724 0.268
+0.027 -0.254 0.281
Notes.
1. Titres analysed as log (titre).
10
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Table XXIII
Clinical cases of rotavirus associated diarrhoea and their 
severity in recipients of rotavirus vaccine and in controls.
1
GROUP N CASES MILD SEVERE NOT EXAMINED
A 78 24 (31%) 2 20
(rotavirus and oral polio)
B 83 34 (41%) 5 21 8
(placebo and oral polio)
C 92 23 (25%) 1 20 2
(rotavirus and killed polio)
A + C 170 47 (28%) 3 40 4
(combined rotavirus vaccine groups)
NOTES
1. These children had a laboratory diagnosis of rotavirus 
but were not examined by a clinician.
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Table XXIV
Comparison of severity scores in cases of 
associated diarrhoea by vaccination group.
GROUP NUMBER MEAN
A 22 5.77
(rotavirus and oral polio)
B 26 5.11
(placebo and oral polio)
C 21 5.71
(rotavirus and killed polio)
rotavirus
S.D.
1.57
1.34
1.31
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Post-vacc i_nat ion Ant i_bodv and C l_i_n i_cal_ Protect ion ._
There was no convincing evidence that clinical protection
could be correlated with post-vaccination rotavirus antibody
levels. Analysis was confined to 115 vaccinees and 55
controls who had their post-vaccination samples taken at
least 4 weeks before the onset of the epidemic. There was no
significant difference between the mean antibody level of
those who subsequently became cases and those who did not (t
= 0.79. n.s.) and the proportion of children showing an
increased antibody titre in response to vaccination was
2
similar in both groups (X = 0.52, 1 d.f., n.s.) (Table
XXV). There was no significant trend towards lower attack 
rates in those with higher post-vaccination titres (Table
XXVI).
Polio. Neutr a l_i_s i_ng Antibody Leve l_s before and after
Vacc i.n a t i.o n._
~\
Polio neutralising antibody levels were measured after 
administration of 1 and 3 doses in children who received 
oral polio vaccine and rotavirus vaccine (group A), or 
placebo (group B). No difference was observed in the mean 
antibody response, or the number of vaccine failures 
(defined as a titre of less than 1:10) after 1 dose of 
vaccine. Mean antibody levels for polio types 1 and 3 were 
lower, and the number of vaccine failures higher in infants 
who received polio vaccine with three doses of rotavirus 
vaccine than in those who had received placebo (table XXVII) 
but these differences did not reach statistical significance
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Table XXV
Mean titres and changes in titre of rotavirus neutralising 
antibody in response to 3 doses of rotavirus vaccine in 
children who subsequently became cases and those who did 
not.
1 2 3
Group N Mean post- 95% C.I. Increase Static Decrease
vaccination 
t itre
4
Cases 40 139 100 - 194 14 0 26
Non-
cases 75 166 128 - 215 33 8 34
Notes
1. Post-vaccination titre one or more dilutions higher than 
pre-vaccination.
2. Post-vaccination titre same dilution as pre-vaccination.
3. Post-vaccination titre one or more dilutions lower than 
pre-vacc inat ion.
4. Cases and non-cases constitute 115 children from groups 
A+C with post-vaccination samples taken one month prior 
to the onset of the epidemic.
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Table XXVI
Rate of clinical rotavirus cases by post-vaccination 
rotavirus neutralising titres in 115 vaccinees and 55 
controls who had post-vaccination blood samples taken at 
least one month prior to the onset of the epidemic.
Attack Rates
Titre Vaccinees Controls
< 80 8/24 (33%) 10/27 (37%)
80 or 112 10/29 (34%) 7/12 (58%)
160 or 224 11/29 (38%) 6/12 (50%)
> 224 11/33 (33%) 1/4 (25%)
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Table XXVII
Polio neutralising antibody: geometric mean titres and and
vaccine failures in samples taken one month after three 
vaccinations with either rotavirus vaccine and oral polio 
vaccine of placebo and oral polio vaccine.
Group Number
of
Vacc inees
Number 
of 
Vacc ine 
Fai1ures 1
POLIO 1
irotavirus/po 1 io 
placebo/po1io
87
95
19 (22%) 
16 (17%)
POLIO 2
rotavirus/polio 87 
placebo/polio 95
POLIO 3
rotavirus/polio 87 
placebo/polio 95
5 (6%) 
5 (5%)
42 (48%) 
38 (40%)
Geometr ic 
Mean 
Titre
281
398
977
977
69
120
95% Cl
172-461
256-618
693-1377
713-1339
44-108
75-192
Notes.
1. Vaccine failures defined as titres < 1:10.
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Serol^ogi_ca 1_ Compari.s on s of Oral, and Intramuscular Poiio Vacci.nes.
Table XXVIII shows a comparison of serological response to
oral polio vaccine (groups A and B combined) and the I.M.
polio vaccine (group C). The polio 3 antibody response to
three doses of I.M. polio vaccine was significantly higher
than that to three doses of oral vaccine (t = 3.3, p <
0 .001), and the number of titres less than 1:10 (considered
2
to be vaccine failures) was significantly lower (X = 38.6,
1 d.f., p < 0.001). There was no significant difference in
polio 1 antibody titres but a significantly higher number of
2
children vaccinated orally failed to respond (X = 5 . 1 ,  1
d.f., p < 0.05). In the case of polio 2, children vaccinated
orally had higher antibody levels (t = 7.25, p < 0.001) with
a significantly lower failure rate than children given I.M.
2
polio (X = 6.3, 1 d.f., p < 0.02).
The relative value of a booster dose at the age of 
approximately one year, of either vaccine in both groups, 
was then analysed. For polio types 1, 2 and 3 the boost
achieved by the I.M. vaccine was better than the oral 
vaccine boost, irrespective of the initial vaccine given, 
although not at a statistically significant level for polio 
2.
El_ectropherotype of Botavpr uses
As was reported in Chapter IV, rotaviruses from the 73 cases 
with an adequate volumes of stool sample had their R.N.A. 
electropherotype determined. The majority of cases (67/73
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Table XXVIII
Hie antibody respeise to three doses of oral or I.M, polio vaccine 
in M )  Sasbisn children and their responses to a single booster dose of oral or I.H. vaccine.
INITIAL three doses
groiyp n geometric 95/i Cl failures 
lean titre
POLIO
ora.
IH
PGLTf!
ora
IH
182 339 244- 470 35(19%)
98 251 184- 342 8<8%>
182 977 776-1231 10(5%)
98 209 144- 304 15(15%)
ora
IH
Pos
I 182 93 69- 126 80(44/
98 234 173- 318 7(7/.)
t-vaccination antibody titre < 1:10.
BOOSTING DOSE
boost
nr=l
IH
geometric 95% 01 
lean titre
661
1585 930-2702
oral 29 468 220- 994
IH 33 1514 983-2332
failures oral/I.H.
cotparissi
10(19%) t = 2.1, 
p < 0.05
7(12%)
4(14%) t = 2.7,
p < 0.01
0(0%)
oral
IH
oral
IH
oral
52 1778 1253-2525 1(2%) t = 1.1
58 2692 2013-3593 1(2%)
29 912
33 1230
102
SO 7AS
oral
IH
29
33
263
891
391-2126
811-1866
56- 188 
129- 466
110- 629 
543-1462
3(10%) t = 0.6, 
n.s.
0(0%)
23(44%) t = 1.9, 
p * 0.05
18(31%)
6(21%) t = 2.5,
p < 0 .02
1(3%)
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(92%)) were caused by rotaviruses with short R.N.A.
patterns, made up from three distinct electropherotypes 
(numbering 17, 23 and 27 respectively). Samples from older
children collected in Bakau, the Medical Research Council 
clinic, and a neighbouring community during the epidemic
'confirm that these short pattern R.N.A. e1ectropherotypes
were the dominant rotaviruses during the 1985/86 epidemic. 
Subgrouping and serotyping of these viruses was attempted 
but proved impossible for technical reasons.
DISCUSSigjL.
The major finding in this study was that administration of 
the bovine rotavirus vaccine, RIT 4237 to Gambian infants 
gave only limited protection against clinically significant 
rotavirus associated diarrhoea, a finding similar to that 
recently reported from Rwanda (151). The vaccine efficacy 
was estimated to be 33% and I am reasonably confident that
this figure gives an accurate measure of the performance of
RIT 4237 in The Gambia. My confidence stems from the fact 
that we were able to detect diarrhoea and collect stools
from the study children in nearly 90% of all diarrhoeal
episodes so it is unlikely that many cases of rotavirus
associated diarrhoea escaped our attention. The lack of 
information relating to other viruses or bacteria which
might have been causing diarrhoea was a weakness in this
\
study but, as I argued earlier in the text, clinical cases 
of rotavirus associated diarrhoea were distinctive both in 
the way they presented and the severity of symptoms reported
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and such data as I was able to collect gave no indication 
that mixed infections were common. For these reasons it 
seems reasonable to propose that the majority of the 
rotavirus associated cases of diarrhoea were caused by that 
agent. A further safeguard was the comparability of vaccine 
and control groups such that diarrhoea associated with 
rotavirus, as distinct form diarrhoea caused by rotavirus, 
should have been equally represented in each group. It is
also perhaps of interest that during a recent trial of a
rhesus rotavirus vaccine candidate, carried out in 
Venezuela, laboratory investigation of the stool samples was
similarly confined to the detection of rotavirus antigen by
ELISA (152).
The low efficacy of the RIT 4237 vaccine in The Gambia was, 
however, a disappointment. Widespread use of such a vaccine 
would not be cost effective and, with the development of
other rotavirus vaccine candidates, it would seem prudent to
wait for a more effective vaccine to become available. With 
the apparent success of the RIT 4237 vaccine in Finland 
there are important questions to answer in relation to this 
study. These questions are, however, difficult to answer 
because our study was not designed to look at these complex
issues but was kept deliberately simple so that an
unequivocal answer could be found to the question of vaccine 
efficacy. As a consequence, much of what follows might best 
be described as speculative.
The Finnish studies (111, 127) used one and two doses of RIT
4237 respectively but the results were essentially similar.
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Children aged 6 - 1 2  months were vaccinated. The majority 
were seronegative at the time of vaccination and 50%
seroconversion rates were achieved. The vaccine gave poor 
protection against rotavirus infection, but greater than 80% 
protection was achieved against clinically significant 
rotavirus episodes. The majority of cases were caused by a 
subgroup II serotype 1 rotavirus, but the second study (127) 
also gave some evidence of protection against infection by a 
subgroup I serotype 2 virus. The vaccine itself is of 
subgroup I, and has a non human serotype (124).
There are a number of possible explanations for the
difference in efficacy of KIT 4237 in Finland and The 
Gambia. Firstly, there may have been important differences 
between the vaccinated children in the two countries, such 
as their pre—vaccination immune status and breast feeding 
practices. Secondly, there may be important differences in 
rotavirus epidemiology and disease severity between the two
environments. Thirdly, the strain of wild virus causing the
outbreaks may have been different. Finally, the
microbiological backgrounds against which the two studies 
were conducted were almost certainly very different.
In The Gambia, rotavirus has its maximum clinical impact on 
infants so vaccination was carried out early and the 
children were younger than the vaccine recipients in
Finland. In Finland the majority of children were
seronegative when they came for vaccination. In The Gambia 
all pre-vaccination blood samples showed detectable levels
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of neutralising antibody. High levels of antibody in very 
young children have been reported in previous studies and 
the assumption is that they are of maternal origin 
(153,154). It is well known that with some other vaccines 
(e.g. measles) the presence of maternal antibody can have a 
deleterious effect on vaccine efficacy (155) so it is 
possible that the high levels of pre-vaccination antibody to 
rotavirus, in the Gambian children, contributed to the 
relatively poor performance of RIT 4237.
Maternal antibody is not the only potential factor which 
may have inhibited antibody response. At present we can only 
speculate on the possible effect breast feeding in The 
Gambia may have had on rotavirus vaccination. It has been 
shown that RIT 4237 may lose infectivity if exposed to 
gastric acidity (156). When an antacid substance like milk 
is given with the vaccine the serologic response rate is 
increased. In Finland breast and formula milk have been 
shown to be almost equally suitable (128) but it is possible 
that Gambian breast milk contains substances harmful to the 
vaccine virus. Such factors may be IgA or other non-specific 
inhibitors of virus growth. Breast milk has been shown to 
contain antibody to rotavirus (157) and non-antibody factors 
(92) which can neutralise rotavirus. Not surprisingly, 
therefore, breast feeding has been shown to modify the 
severity of rotavirus infection but the level of protection 
provided is not sufficient to reduce the risk of infection 
(158,159). During the planning stage of the rotavirus 
vaccine trial, I was asked by the manufacturers of the RIT 
vaccine to give artificial formula milk to the children at
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the time of vaccination. I refused to do this because of the 
very considerable danger that such a policy might help to 
promote artificial feeding in a community which has 
traditionally relied almost exclusively on breast feeding. 
Mothers in Bakau feed their children on demand and usually 
gave them breast milk immediately after a vaccination to 
provide comfort. I decided to allow the mothers to continue 
this practice as it would have been pointless to try to 
modify this very well established behaviour pattern. Breast 
milk samples were, however, collected from all the mothers 
prior to the first vaccination. It would be interesting to 
measure the rotavirus neutralising capability of these 
breast milk samples and relate these results to the 
vaccination response in individual children and also to 
compare Gambian breast milk with samples from nursing 
mothers in Finland.
It is difficult to make a confident statement about the 
antibody response to FIT 4237 in our trial. Declining 
maternal antibody levels made interpretation of our 
serological data more difficult than it would have been if 
children had been seronegative at the time of vaccination. 
In the presence of a background of declining maternal 
antibody, it is reasonable to consider any increase in titre 
to be a vaccine response, a decrease a non-response, and an 
unchanged titre intermediate. Within the two vaccinated 
groups the rotavirus neutralising antibody response of 
individuals showed considerable variation, but following 
vaccination the mean antibody levels in vaccinees were
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significantly higher than in the controls. A higher
proportion of vaccinees showed an increase in neutralising 
rotavirus antibody titre following three vaccinations than 
did controls but less than half the children in our study
showed any evidence at all of producing serum neutralising
antibody in response to vaccination and only a quarter 
increased their titres by two dilutions or more. It is, 
therefore, difficult to compare the vaccine response in The 
Gambia with previous trials although it is perhaps not 
unreasonable to argue that vaccine take was poor.
Another indication that vaccine take was poor was our 
inability to detect any evidence of post-vaccination
rotavirus excretion. Stools were collected daily from a 
subgroup of children for a week after vaccination. In 
addition, many children had stools examined in the post- 
vaccination period because they developed a coincidental 
episode of diarrhoea (diarrhoea was not more commonly 
detected in the post-vaccination period). None of these 
samples had rotavirus present in sufficient quantities to be 
detected by ELISA. Nor was there any evidence that the 
vaccine virus was circulating in the community as none the 
viruses which we were able to electropherotype showed the 
bovine vaccine pattern of migration.
Since the rotavirus vaccine was given orally some of the 
vaccine virus would, undoubtedly, have made its way out in 
the stool. Our failure to detect vaccine virus in the stool 
probably means that replication of the virus in the gut was 
such that concentrations of the vaccine virus remained
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fairly low. A similar finding has been reported with the 
oral polio vaccine in the tropics in as much as even when 
the vaccine does take only small amounts of virus are 
excreted in the stool. In the case of oral polio the low 
concentrations of virus in the stool are associated with a 
poor immunological response to the vaccine so it might be 
reasonable to postulate the same for rotavirus. It should, 
however, be pointed out that there was no apparent post­
vaccination excretion of the FIT 4237 vaccine virus during 
the Finnish studies either so it is not possible to argue 
that the apparent absence of vaccine virus in the Gambian 
stools provides evidence of poorer vaccine take, at least 
compared with the Finnish studies. However, it is likely 
that there was poor replication of the vaccine virus in the 
gut as reflected in the poor serological responses observed 
in our study.
In our study the absolute level of post-vaccination 
neutralising rotavirus antibody did not correlate with 
clinical protection. This suggests that the neutralising 
antibody measured in our study was not in itself 
protective. It is not at present clear which part of the 
immune response is the most protective but most 
investigators seem to be agreed that local gut immunity 
appears to have the greatest protective role (88,89,90). 
Consequently serum antibody is not always a reliable 
indicator of protection. Fecent studies have, however, shown 
the value of measuring neutralising antibody against each of 
the four main serotypes known to infect man. Neutralising
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antibody measured in this way does seem to correlate with 
protection against subsequent infection with a rotavirus of 
the same serotype and, to a lesser extent, heterotypic virus 
infection (68). In our study we measured the neutralising 
capability of serum samples against the bovine vaccine 
virus. This measure has provided a reasonable index of the 
antibody response to vaccination but, perhaps not 
surprisingly, it did not correlate with clinical protection.
A further area for speculation is the possible effect that 
the high frequency of enteric viruses and other pathogens in 
The Gambia may have had on the immune response to rotavirus 
vaccination. It should be remembered that the background 
against which any virological work in the tropics has to be 
done is that of a very considerable load of natural 
infection with, mostly, enteroviruses. As their name 
suggest, the enteroviruses (polio viruses, coxsackie A 
viruses, coxsackie B viruses and echoviruses) inhabit the 
intestinal tract and poor hygiene aids their dispersal 
(161). As a consequence enteroviruses are frequently 
encountered in the intestines of children in the tropics. 
When a vaccine virus is introduced into the gut at the time 
of oral vaccination there is at least a theoretical 
possibility that viral interference between the two viruses 
will take place.
This problem came to prominence when it was discovered that 
the measured serological response to oral polio vaccination 
was much poorer in warm than in temperate countries 
(162,1635. Factors implicated as the cause of this poor
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response include breast feeding, inhibition by circulating 
enteroviruses and a gastrointestinal or salivary inhibitor.
Although polio virus can be 
this is thought not to be 
seroconversion rates have 
breast-fed Ugandan infants 
feeding (160). In addition, 
improve conversion rates by 
varying periods before
inhibited by breast milk (164) 
the major suppressive factor as 
been shown to be similar in 
and those receiving artificial 
Indian investigators could not 
thholding breast feeding for 
after immunisation (165).
wi 
and
Although circulating enteroviruses have been suggested as 
the cause of the poor response to oral polio in the tropics, 
reports on the importance of enterovirus infection are 
conflicting. Several studies have reported that infants 
carrying enteroviruses at the time of vaccination have a 
lower antibody response than controls (160), but such a 
correlation was not found in studies carried out in Nigeria 
(166) and India (167). Thus it seems possible that some form 
of local gastrointestinal inhibitor may be the cause of the 
poor serological response to oral poliovirus obtained in the 
tropics.
The whole issue of virus interference is, however, highly 
complex and still a matter of great debate. Interference 
phenomenon are important in the context of this study for 
the following reasons. It is important to demonstrate that
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the simultaneous administration of the two oral vaccines did 
not have any detrimental effect on each other. If naturally 
circulating enteroviruses do have a detrimental effect on 
the immune response to the oral polio vaccine it is at least 
possible that the deliberate introduction of the rotavirus 
vaccine virus would add to this effect. It is also possible 
that naturally circulating enteroviruses inhibited the
immune response to the rotavirus vaccine RIT 4237. This is 
certainly the explanation favoured by the investigators in 
Rwanda (151) who conducted a smaller but equally 
unsuccessful trial of RIT 4237 but some of our results seem 
to contradict this conclusion.
In the Gambian trial rotavirus vaccine was administered with 
oral polio vaccine in group A and with killed polio in group 
C. There was, however, no evidence that the concurrent
administration of oral polio vaccine and RIT 4237 had any 
adverse effect on the rotavirus vaccine response. It is this 
fact which casts doubt on the theory that the poor response 
to RIT 4237 was due to interference from naturally
circulating enteroviruses. If the mean post-vaccination 
antibody levels and the rotavirus vaccine response rates
were almost identical for children who received oral polio 
(an enterovirus) and those who received placebo at the time 
of rotavirus vaccination it is hard to see how naturally 
circulating enteroviruses could have had a detrimental 
effect. It is, none the less, clearly possible that the same 
sort of factors which inhibit the response to oral polio in 
the tropics were having a similarly negative effect on the 
rotavirus vaccine. The identity of such a factor or factors
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is presently open to speculation*
There was some evidence that the rotavirus vaccine 
interfered with the immune response to the oral polio 
vaccine. Antibody levels to polio type 1 and 3 were lower in 
infants who received concurrent rotavirus vaccine than in 
controls. During the course of the trial polio antibody 
levels were analysed elsewhere in batches. When, after 3 
batches of sera had been analysed, a statistically 
significant difference between the two groups was obtained 
the trial was stopped prematurely. Subsequent analysis of 
further batches of sera did not show such a marked 
difference between groups although the trend for lower type 
1 and type 3 antibodies in those who had received rotavirus 
vaccine remained. Interference might be increased if a new 
less attenuated rotavirus vaccine virus was used and the 
issue of mutual interference between these two vaccines will 
require careful consideration in future rotavirus vaccine 
trials. All vaccine trial participants received a booster 
dose of oral or intramuscular polio vaccine after the trial 
had been concluded.
Whatever effect the rotavirus vaccine had on the response to 
oral polio vaccination the effect was small compared with 
that caused by whatever factors are operating in all 
tropical environments to compromise the response to oral 
polio immunisation. The results from the control group 
confirm those from other studies that oral polio vaccine 
frequently fails to result in adequate seroconversion.
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Interestingly, the response to killed intramuscular polio in 
group C was, on the whole, better than that of either oral 
polio group (A or B). From a serological viewpoint, three 
doses of I.M. polio vaccine were better overall than three 
oral doses. This trend was reversed for polio 2 but both 
vaccines gave good responses and low failure rates for polio 
2, so I considered this to be relatively unimportant. Since 
higher failure rates were observed in polio types 1 and 3 
after three doses of oral vaccine, these types would be the 
logical focus of attention in considering the value of 
booster doses. In both cases, the I.M. vaccine performed 
better as a means of boosting irrespective of the initial 
polio vaccine regime. It should be emphasised, however, that 
serological response is only one of many factors which 
should be considered in selecting a vaccine for widespread 
use, particularly in developing countries.
These results add weight to the view that, despite the 
undoubted success of oral polio vaccination programmes 
throughout the world, there are nonetheless several reasons 
why the relative merits of oral and intramuscular 
vaccination should be reviewed (168,169). This issue is 
particularly relevant in The Gambia where there has been a 
major outbreak of paralytic polio since our study was 
completed despite a high level of vaccination coverage. 
Between April and November of 1986, 237 cases of paralytic
polio occurred resulting in 19 deaths. Although none of the 
children involved in our studies developed polio many cases 
occurred in children who had been fully vaccinated at 
centres where the integrity of the cold chain could be
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guaranteed. The epidemic was investigated by epidemiologists 
zx$
from the Centre for Disease Control in Atlanta. I supplied 
them with the serological data we had collected and, 
following a detailed investigation, they concluded in their 
report to the Gambian Government that "the most likely 
explanation for the Gambian epidemic was that, despite good 
vaccination coverage, a proportion of children did not 
respond to the vaccination and were, therefore, susceptible 
to paralysis".
The Department of Medical and Health in Banjul decided to 
respond to the problem by employing the tactic, initially 
tried in India (170), of increasing the number of doses of 
oral polio vaccine used. Since the end of 1986 Gambian 
children have receive five doses of the oral vaccine during 
the first year of life.
Rotavirus vaccination did not decrease the severity of 
subsequent rotavirus infections in The Gambia. Our analysis 
was confined to the 85% of all detected rotavirus cases who 
were seen and examined by a study clinician. The remaining 
15% may have suffered milder attacks but this cannot be 
assumed as mothers had been taught how to administer water, 
sugar and salt solution and sometimes treated their own 
children at home despite our request to see the child during 
the acute phase of each episode. Of the cases seen by a 
clinician the majority (88%) suffered a severe attack, as 
defined by the W.H.O. guidelines, and all of the detected 
episodes lasted more than 24 hours. There was, however, no
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significant difference in the proportion of severe cases in 
the vaccinated and non vaccinated groups. It is possible 
that the children in our study had, in general, more severe 
episodes of diarrhoea than those in the Finnish studies, 
perhaps because they were exposed to a higher infecting dose 
of virus.
He are not able to say from the available data whether the 
strain of infecting virus contributed to the poor vaccine 
performance but this is clearly an important issue which 
needs to be addressed in the future. The rotaviruses 
responsible for the Gambian outbreak were predominantly of a 
short electropherotype. Experience to date suggests that 
rotaviruses with short electropherotypes belong to subgroup 
I serotype 2. The predominant virus in Finland has been of 
subgroup II serotype 1, although the second study did 
demonstrated some evidence of protection against natural 
infection with a subgroup I serotype 2 virus (127).
I am, therefore, unable to provide a single adequate 
explanation for the failure of the rotavirus vaccine in The 
Gambia. The poor level of protection provided by RIT 4237 in 
this study is probably best explained by a combination of 
factors including the relatively severe spectrum of 
rotavirus infection, the younger age of administration 
associated with high levels of pre-vaccination antibody and 
local factors which may have decreased the vaccine take.
The possibility that naturally circulating viruses, or some 
other as yet undefined factor, interfered with the rotavirus
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vaccine is clearly an important but complex issue which 
requires further investigation. However, from a practical 
community health perspective it is clearly much more 
important to find a vaccine which will protect children in 
this environment even if we do not understand why our 
previous effort failed.
An effective and inexpensive rotavirus vaccine would make an 
important contribution to the control of severe, acute 
diarrhoeal disease in The Gambia. A less attenuated vaccine 
may now be required but future trials of further rotavirus 
vaccines are certainly justified.
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CHAPTER VII 
FACTORS AFFECTING VACCINE COMPLIANCE
INTRODUCTION^
If disease due to rotavirus is ever to be fully prevented in 
The Gambia by vaccination, then an effective new vaccine 
will have to be administered through an efficient vaccine 
delivery system. By African standards The Gambia is 
relatively small which facilitates the delivery of health 
care. It has a well developed national Maternal and Child 
Health (M.C.H.) programme of which its Expanded Programme 
for Immunization (E.P.I.) is an important part. 
Consequently, the country’s population has a high rate of 
access to basic health services including immunisation. 
Vaccination coverage was measured in 1984 when it was found 
that 48% of children were fully immunised (171). Despite the 
success of the E.P.I. programme in The Gambia, coverage has 
not been uniform and the country still experiences serious 
measles outbreaks and in 1986 suffered a major outbreak of 
paralytic poliomyelitis.
Experience in other developing countries suggests that poor 
vaccination compliance is usually the result of poor 
availability or delivery of vaccines combined with problems 
of belief, attitude and perception in the families of 
potential vaccine recipients (172,173,174). In the towns of 
The Gambia, vaccine availability and delivery is not a major 
obstacle to effective vaccination but a significant minority 
of children still remain unvaccinated or poorly vaccinated.
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It seemed possible that these poorly vaccinated children
might share common features with respect to family 
background or socioeconomic status and if these could be 
identified the task of targeting "at risk" children would be 
facilitated. This project was devised at the beginning of 
the rotavirus vaccine trial at which time we anticipated 
that the vaccine would be successful and that knowledge of 
factors influencing vaccine compliance would be important to 
any programme of implementation.
We collected vaccination compliance data retrospectively for 
251 children living in Bakau. As expected, the general level
of vaccine compliance was high, but a significant minority
of children (10%) had received less that, half the expected
number of vaccinations. These children were compared with a 
larger group of children who were fully vaccinated.
Data on 29 socioeconomic and attitudinal variables were 
collected by means of a pre-tested questionnaire (Appendix 
II) which was administered to the children’s mothers by one 
of the investigators who remained blind to the child’s 
vaccination status.
A proportion of the variables showed significant correlation 
with vaccine compliance. These results are shown in Table 
XXIX. All other variables listed in Appendix II showed no 
significant correlation.
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Table XXIX
Variables showing a significant association with poor 
vaccination compliance together with some of the more 
important negative results.
Factor Good Poor Significance
Compliance Compliance
(N=42) (N=23)
Completed primary 
school(mothers)
10 0 X =4.77 
p < 0.05
Completed primary 
schoo1(fathers)
14 X =3.62
p < 0 . 10
Mothers literate 8 X =1.6 
n. s.
Fathers literate 14 X =2.20 
n. s.
Monthly income mean = 3.21
(hundreds of dalasis) s.d. = 2.02
mean = 3.00 
s.d. = 1.28
t = 0.45 
n. s.
*
Number of assets mean = 2.21 
s.d. = 1.09
mean = 1.39 
s.d. = 1.03
t = 2.96
p < 0.01
Number of rooms mean = 2.71 
s.d. = 1.15
mean = 2.61 
s.d. = 0.99
t = 0.35 
n. s.
Mother employed 26 15 X =0.05 
n. s.
Mother self employed 18/26 15/15 X =3.94 
p < 0.05
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Live-born children mean = 3.55 
s.d. = 1.98
mean = 6.17 
s.d. =3.0
t = 4.23
p < 0.001
Had a stillbirth X =4.44 
p < 0.05
Living children mean = 3.12 
s.d. = 1.74
mean = 5.44 
s.d. = 2.50
t = 4.39
p < 0.001
Children had died 13 12 X =2.00 
n. s.
Complaints about 
health centre
9 8 X = 0.77 
n. s.
Number of visits to mean = 14.78 
health centre s.d. = 5.79
mean = 5.57 
s.d. = 3.49
t = 6.96
p < 0.001
Number of weights mean = 10.50
recorded in 1st year. s.d. = 2.96
mean = 4.22 
s.d. = 1.88
t = 9. 17
p < 0.001
Would attend for 
weighing or 
vaccination only
36 X = 24. 1
p < 0.001
Knows at least one 
vacc ine-preventable 
disease
26 7 X =4.70 
p < 0.05
Believes in 
"scientific" cause 
of disease
26 X = 15.06
p < 0.001
Note.
* Assets were 1.Sheep 2. Goats 3. Cattle 4. Land 5. Motorcycle 
6 . Bicycle 7.Radio/Cassette 8 . Refrigerator.
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Access to Immunisation Clinics^
There was no significant difference in the distance mothers 
of well and poorly vaccinated children had to walk to the 
Health Centres.
Education and Socioeconomic Status of Parents^
Both parents of poorly vaccinated children had significantly 
less formal education than parents of well vaccinated 
children. Mothers and fathers spent less years at school and 
a smaller proportion of mothers completed primary education 
while a smaller proportion of fathers finished secondary 
school (table XXIX). There was also a trend towards poorer 
literacy in the parents of poorly vaccinated children but 
this did not reach statistical significance.
There were no differences in family income or housing but 
families of well vaccinated children had more assets and 
consumer goods. Paternal occupations were essentially 
similar, but a significantly larger proportion of the 
mothers of poorly vaccinated children were self-employed 
petty traders.
Atti^tudes of Mothers to Di_sea.se and its Preventions
Mothers of poorly vaccinated children were less aware of the 
diseases against which immunisation was possible (table 
XXIX). Mothers were also asked for their opinion with 
respect to the causes of disease. More than one reply was
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accepted and the replies grouped according to whether
mothers favoured more scientific reasons like contamination
S
of food, dirtiness, nutrition, feeding practices, and poor 
child care, or alternatively more superstitious or 
fatalistic answers like evil spirits and fate. Mothers of 
poorly vaccinated children favoured the less scientific and 
more fatalistic answers (table XXIX).
Mothers were asked under what circumstances they took their 
children to the Health Centre. There was no significant 
difference in the proportion of mothers who replied "when 
the child is sick" but a larger proportion of the mothers 
with well vaccinated children replied that they also took 
the child for weighing and for vaccination even when the 
child was well. This aspect was also reflected in the fact 
that the total number of health centre visits during the 
first year of life, and the number of weights recorded, was 
higher in the well vaccinated group (table XXIX).
Mothers of poorly vaccinated children had significantly more 
children and had experienced more stillbirths. There were, 
however, no significant differences in the reported number 
of deaths occurring among liveborn children.
Analysis by Multiple Logistic Regression^
Since some of the factors found to be associated with poor 
vaccination compliance were highly correlated a multiple 
logistic regression was carried out in order to examine the 
effects of risk factors in combination.
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The independent variables considered were those showing 
statistical significance on univariate analysis, except that 
"number of visits to the health centre" and "number of
weights recorded" were omitted as they were so closely
related to vaccination compliance. The variable representing 
attitude "would attend for vaccination, or weighing, even if 
the child was not sick" was the most important of the 
remaining variables in discriminating between the two 
groups, but an argument of circularity could be invoked
here, and so the data were analysed both with and without 
this variable.
Without "would attend for vaccination or weighing, even if 
the child was not sick", the model which provided the best 
fit to the data incorporated "number of children born
alive", "belief in scientific cause of disease" and "number 
of assets". The addition of other variables to this model 
did not significantly improve its fit.
Of the models which included "would attend for vaccination 
or weighing, even if not sick", the one which proved the 
best fit contained "number of children born alive" and 
"number of assets", but not "belief in scientific cause of 
disease".
Comparison of Vaccination Compliance in 1984 and 1985.
Table XXX shows the results of compliance within the 
rotavirus vaccine cohort (all born in 1985), while table 
XXXI shows the retrospective data we collected in Bakau for
Table XXX
Vaccination compliance during 1985 in Bakau (during the 
rotavirus vaccine trial) for the rotavirus vaccine cohort. 
Children were withdrawn form the study when they outmigrated 
and these figures only relate to vaccinations which were 
carried out during 1985, hence the declining numbers 
eligible for vaccination.
Vac. Number Came within Came after Did not 
eligible one month one month attend
1st 338 332 6 0
(100%) (98%) (2%)
2nd 294 293 1 0
(100%) (100%) (0%)
3rd 250 248 2 0
(100%) (99%) (1%)
Measles 106 101 5 0
(100%) (95%) (5%)
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Table XXIX
Vaccination compliance during 1984 in Bakau (outwith the 
rotavirus vaccine trial) in a group of 153 Bakau children 
still resident in 1985 (information was not available for 
children who had out-migrated). The information was 
collected retrospectively.
Vac. Number Came within Came after Bid not 
attended one month one month attend
1st 151 104 47 2
(99%) (68%) (31%) (1%)
2nd 143 101 42 10
(93%) (66%) (27%) (7%)
3rd 128 90 38 25
(84%) (59%) (25%) (16%)
Measles 103 63 40 50
(67%) (41%) (26%) (33%)
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children born in the first half of 1984. The two groups were 
not exactly comparable since I knew a great deal more about 
the compliance of the vaccine trial cohort and the two sets 
of data were collected in different ways.
Despite these differences, it is possible to make a
comparison between the two groups for vaccination status
within one month of dates on which vaccination should have
been given. Such a comparison shows that vaccination
compliance was significantly higher during the rotavirus
vaccine trial than during the previous year (Hante1-Haensze1
test allowing for differences between vaccination 1 to 3, 
2
X = 33, Id.f., p < 0.001 ). However, the fall-off rate
M-H
between the three vaccinations was not significantly
different when a similar comparison is made with allowance
2
for the pre- and post-trial periods (X = 5.8, 2 d.f.)
M-H
The anthropometry and measles vaccine call made at 39 weeks
in the rotavirus vaccination trial also shows a
2
significantly higher completion rate (X = 77, 1 d.f., p <
0.001)
discussion..
In this survey mothers of poorly vaccinated children showed 
a number of differences from those of well vaccinated 
children. There is little doubt that a number of these 
variables were correlated with each other and it was 
difficult to disentangle which variables are true risk 
factors even with the help of multiple logistic regressional 
analysis. Other surveys examinining aspects of socioeconomic
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status in the Gambia have encountered similar problems 
(109). We did, however, find that the mothers of poorly 
vaccinated children had more children, had fewer assets, 
were less well educated, had less knowledge of the diseases 
their children should be vaccinated against and had a more 
superstitious view of disease causation.
These mothers were also less orientated to the health centre 
as a source of preventive, as opposed to simply curative, 
services. By contrast, the mothers of poorly vaccinated 
children were less inclined to bring their children to the 
Health Centre for weighing and vaccination but tended to 
confine their visits to times of acute illness.
It is possible that the heavier workload involved in looking 
after a larger number of children gave these mother less 
time to visit the health centre. The intense pressure of 
work and family cares of many women in developing countries 
influences their ability to use available health services. A 
similar explanation may underlie the fact that more of the 
mothers of poorly vaccinated children worked as self- 
employed petty traders. These women had to spend a great 
deal of time selling their wares at the local markets, which 
may have decreased their opportunities for visiting the 
Health Centre.
No difference was found in family income although the 
families of well vaccinated children had more assets and 
consumer items. This is surprising as wealth might have been
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expected to correlate to a more marked degree with 
education. It has, however, been pointed out in previous 
studies of Bakau families that the occupation of the father, 
housing, and possession of consumer items are poor indices 
of true family wealth, but they have been used in this study 
in the absence of more suitable indicators.
Studies from other countries have shown that poor vaccine 
compliance is often associated with the difficulties 
experienced by mothers in obtaining vaccinations for their 
child allied to problems of attitude, perception and belief 
(172,173,174). In our study area, vaccination clinics were 
run efficiently on a weekly basis and all mothers had easy 
access to them. None of the mothers interviewed believed 
that vaccination could cause any harm to their child and 
there was no difference between the groups with respect to 
complaints about, or difficulties with, the Health Centre 
staff.
In this study I have identified a number of characteristics 
common to mothers and families of poorly vaccinated 
children. One of the more interesting findings to emerge 
from this study was the relationship between poor 
vaccination compliance and poor education. These poorly 
educated women also had a poorer knowledge of disease and 
vaccines. In the light of this, it would seem logical to 
employ health education techniques to compensate for these 
disadvantages. It has, however, also been demonstrated that 
these mothers pay fewer visits to the Health Centre which is 
the traditional site of most formal health education
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activity. For this reason it may be necessary for the health 
workers to take the health education messages to the homes. 
Fortunately these is a cadre of health workers in The Gambia 
who are ideally suited to confronting this problem. In 
Bakau, and throughout much of The Gambia, Community Health 
Nurses ( C.H.N.s ) form part of the primary health care 
team. Their main function is health education and health 
promotion but there is some doubt about how effectively they 
are fulfilling this role.
Despite the methodological problems involved in comparing 
vaccination compliance for children born in 1985 with 
retrospective data collected for children born in 1984, 
vaccination compliance in Bakau was measureably improved 
during the rotavirus vaccine trial. There were, undoubtedly, 
many reason for this but my strong impression was that the 
major factor which improved compliance was the paying of 
reminder visits to the child’s compound on the day before 
vaccinations were due. Similar visits could be paid by 
C.H.N.s, not only to remind the mothers about vaccination 
but also for health educational purposes. It is clearly 
impractical for this type of visit to be paid to all 
children but it may be possible for C.H.N.s to target "at 
risk" children who have poor vaccination records, thereby 
encouraging the mothers to bring their children. From the 
evidence of this study, self-employed mothers with large 
families and a low standard of education need special help 
if their children are to benefit from preventive health 
measures.
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Other methods of health education could also be usefully 
employed to increase awareness of the importance of 
vaccinations. These include radio messages and posters which 
are already used extensively in The Gambia to promote other 
health activities.
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CHAPTEK VIII
FINAL DISCUSSION AND CONCLUSIONS
r
The World Bank estimates that even if optimistic rates of 
economic growth are achieved in the developing world, there 
will still be 600 million people trapped in a state of 
absolute poverty in the year 2,000, This, the Bank defines 
as a condition of life so characterised by malnutrition, 
illiteracy, disease, high infant mortality, and low life 
expectancy as to be beneath any reasonable definition of 
human decency. The number of people in the world who are not 
in a state of absolute poverty, but none the less suffer 
from preventable disease and a low standard of living, is 
much larger. The existence of such an enormous reservoir of 
human disease and suffering is a challenge not just to the 
medical profession, but to the world at large. Medical 
personnel, on their own, can do very little to change the 
lot of the most disadvantaged people in the world but health 
care and promotion is a vital ingredient in any 
comprehensive development programme.
The World Health Organisation has responded to this 
challenge with its "Health for all by the year 2,000" 
programme. This programme has emphasised the need to take 
medical care out of the hospitals and into the community, 
where low cost treatments can be delivered by village health 
workers. As this programme has gathered momentum, so too 
have a number of problems and questions become evident. What 
are the most cost effective interventions? How can the
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consumer’s desire for good treatment of diseases be married 
to the obvious need for disease prevention? Can efficient, 
sustainable primary health care programmes be maintained 
without continuing international financial support and 
expert i se?
Those of us who are involved in tropical medicine research 
need to be sensitive to these issues. It is very easy for 
the research agenda to be unconsciously set by academics 
working in the rich industrialised countries. From such a 
context basic scientific issues seem more important and it 
is easy to depreciate the value of operational research and 
investigations into social and environmental issues. On the 
other hand, doctors working in the developing world are 
acutely aware of the urgency of the need. Both sets of 
values are clearly required but in practice a compromise has 
to be arrived at. The research I carried out in The Gambia 
was one such compromise.
The development of oral rehydration solutions has 
revolutionised the treatment of diarrhoea but, despite this, 
several million children die every year in the Third World 
from a condition which is usually little more than a mild 
inconvenience in Europe or North America. The basic problem 
is that a mother still needs to mix the water, sugar and
salt solution in the correct quantities and give enough of
it to her sick child. This requires knowledge of how to mix
the solution and the necessary discernment to start
treatment in time. For these reasons effective management of
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diarrhoea will continue to be a problem, although oral 
rehydration therapy is a vitally important development which 
is presently saving many lives throughout the world.
These difficulties, encountered with even simple treatment 
measures, make vaccination an even more attractive 
proposition in the developing world. Vaccination to prevent 
any form of diarrhoea would also have the added benefit that 
it would prevent the weight loss which is known to be 
associated with repeated diarrhoeal episodes.
It was within this context that the rotavirus vaccine RIT 
4237 was developed. The case for a rotavirus vaccine was 
effectively argued soon after this virus was discovered, but 
it would be wrong to overestimate the potential benefits. 
From the evidence of the work carried out in Bakau, complete 
elimination of rotavirus disease would only reduce the total 
diarrhoea burden on children less than 2 years old by less 
than 10%. This figure reflects the extraordinarily high 
frequency of diarrhoeal episodes in young Gambian children 
but, looked at from another perspective, it is equally true 
to say that rotavirus vaccination could prevent a severe and 
potentially life threatening illness in one third to one 
half of all infants. Rotavirus vaccination would also have a 
disproportionate impact on hospital admissions with 
gastroenteritis as rotavirus has been shown to cause a 
relatively severe illness.
I have no data to prove that more severe episodes of 
diarrhoea are associated with greater weight loss but such a
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hypothesis has a strong theoretical basis. Approximately 
half of all rotavirus cases experienced obvious weight loss 
in the post infection period. This issue clearly requires 
further study.
Another issue, arising from our observations, which requires 
further investigation is the relationship between climate 
and rotavirus infection. The very strict epidemic nature of 
rotavirus in The Gambia, occurring as it does at exactly the 
same time each year, and the highly predictable change in 
season which precedes the epidemic by a matter of weeks, 
point to an association between climate and rotavirus 
survival in the environment. Experiments relating 
atmospheric humidity and temperature to rotavirus survival 
on fomites would be an obvious approach to this problem.
A great deal remains to be discovered about the epidemiology 
of different rotavirus strains. Our studies have not added 
greatly to this knowledge, but The Gambia is now rare among 
developing countries in that rotavirus epidemiology has been 
studied for four consecutive years and data have been 
collected on the R.N.A. electropherotypes circulating in the 
community during each of these years. A limited amount of 
data is also available concerning the subgroup and serotype 
of rotaviruses circulating in Bakau during this period. If 
these observations are continued it should be possible to 
define strain-specific characteristics.
My failure to identify specific risk factors for rotavirus
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infection does not in any way reduce the need for 
improvements in housing, sanitation water supply etc., but 
it does underline the fact that improvements in health will 
come about only when a wide range of improvements are made 
in living standards and that it is relatively futile to 
search for individual environmental interventions.
There is also a need to discover a great deal more about the 
microbiological environment of children in The Gambia. In 
particular, efforts should be made to determine the 
aetiology of diarrhoea and further define the effect of
enteroviruses on polio and other oral vaccines. Such work
would require individuals with a high level of expertise in 
various aspects of laboratory science and so, given the
present availability of funds and the medical priorities in 
The Gambia, it seems unlikely that such work will be carried 
out in the near future. Whether it is right to pursue
vaccination trials while such knowledge is lacking is open 
to debate but my own feeling is that research in the tropics 
has to be the art of the possible and the need is so great 
that any vaccine with a reasonalbe chance of success should 
at least be assessed.
The relatively poor performance of the rotavirus vaccine KIT 
^  4237 in The Gambia was a major dis^apjointment but a variety 
of other candidate vaccines are nearing the stage of field 
trials and it is possible that a new vaccine will be more 
successful. From the evidence of the trial of KIT 4237, any 
new vaccine will need to be more immunogenic and it is 
possible, but as yet unproven, that it will have to be
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polyvalent, containing each of the major serotypes.
The age of administration is now an important issue. In The 
Gambia maternal antibody levels to rotavirus in young 
children were high and may have had a detrimental effect on 
the response to vaccination with RIT 4237. Whether a more 
immunogenic vaccine could overcome the effect of maternal 
antibody remains to be seen, but it would be a major 
disadvantage if rotavirus vaccination had to be delayed 
until the second half of the first year of life.
Vaccination as early as possible in life is not only 
important because the disease affects all infants, but also 
because the compliance to vaccination is higher for vaccines 
given during the first six months of life when the child is 
brought for other vaccinations and weighing. Although we 
were able to improve the overall vaccine compliance of the 
children in our study, compared with historical controls 
born the previous year, the relative fall-off in vaccination 
compliance for D.P.T. and polio (administered at two, three, 
and four months) to measles and yellow fever (administered 
at nine months) was not improved, which shows that whatever 
the overall level of compliance, there is a clear advantage 
if a vaccine can be given before six months of age and at 
the same time as D.P.T. and polio.
Rotavirus vaccination in The Gambia would only be justified 
if an effective vaccine could be developed which was 
relatively inexpensive. The cost of RIT 4237 was not known.
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The market price of any future vaccine would obviously 
depend on a large number of factors* As was argued earlier 
in the text, administration of rotavirus and oral polio 
vaccines together would reduce the delivery cost of the new 
vaccine, but we were not able to exclude a negative effect 
on oral polio vaccination by the rotavirus vaccine. Any new 
vaccine would have to be assessed carefully with respect to 
this potential interaction.
In conclusion, it can be said that there are several ways of 
reducing morbidity and mortality due to diarrhoeal disease 
in general, and rotavirus infection in particular, in The 
Gambia. These interventions are effective rotavirus 
vaccination, a general rise in living standards and 
effective treatment of acute cases when they arise. It is to 
be hoped that the long-term goal of a rise in living 
standards will eventually come to The Gambia and that it 
will not be long before an effective and inexpensive 
rotavirus vaccine is available.
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APPENDIX I
Var i_aMes recorded on rotavirus ri.sk factors g_uest ionnai.re^
Variables concerning the compounds and dwellings.
Compound Hived in by case/contrqii^
No. of buildings in compound ? (counted)
No. of people in compound ? (personal census)
No. of children less than 3 years in compound ?
No. of children less than 2 years ?
No. of European style houses in the compound ?
No. of Cement/corrugate houses in the compound ?
No. of Hud/corrugate houses in the compound ?
No. of Hud/thatch houses in the compound ?
Dueiiing loccupied by case/cqntroJ._)
No. of people sharing house ?
No. eating out of common bowl ?
No. under three years ?
No. under two years ?
No. sharing bedroom ?
No. sharing bed ?
No. living in European style house ?
No. living in Cement/corrugate house ?
No. living in Hud/corrugate house ?
No. living in Mud/thatch house ?
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Rater supply and storage^
Mean distance to standpipe (measured in metres) ?
No. storing water in clay jars ?
No. storing water in metal pots ?
No. storing water in plastic buckets ?
No. storing water in glass bottles ?
No. of people using water ?
No. of children using water ?
No. of times/day water collected ?
No.of times/day containers cleaned ?
Sani.tati.on faci.l.i.ties and behavpour._
No. using same pot ?
No. of children using the ground ?
No. of children using a nappy ?
No. of compounds with a latrine ?
Type of sanitation used by adults in dwelling/compound ?
Hygiene and cleanlj.ness^
No. of times compound swept daily ?
How frequently does mother wash her hands ?
Does mothers prepare fresh food for each meal ?
Does mother prepared fresh food for the child daily ?
Does mothers prepare fresh food for child less than daily ?
Cleanliness/tidyness score allocated by field assistant 
on a 0 - 5 scale
Is case/control child allowed to sit on the ground ?
Is case/control child in the habit of eating sand ?
Is the same broom used for inside and outside the house ?
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AnimaJ. Contacts
Is the case/control child.......
In contact with cows ?
In contact with goats ?
In contact with sheep ?
In contact with pigs ?
In contact with dogs ?
In contact with cats ?
In contact with chickens ?
Famj.J.y background^
Is the mother Mandinka/Wo1lof/Fulla/Jo 1 la/other tribal group ?
Is the father Mandinka/Wo1lof/Fulla/Jo 1 la/other tribal group ?
Is mother married/unmarried/divorced/widowed ?
Is the fathers living in compound ?
Is the mother in paid employment ?
Mean number of sibs ?
No. of stillbirths/abortions experienced by case/control’s 
mother ?
No. of deaths in sibs ?
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Parenta 1_ edu.cati.on and atti.tu.de to disease^.
Years of maternal education ?
Did mother finishing primary school ?
Did mothers finishing secondary school ?
Years of paternal education ?
Did fathers finishing primary school ?
Did fathers finishing secondary school ?
Mothers were asked an open ended question about the cause of 
disease and illness in their children. Many answers were 
given but the catagories were contracted down to simply 
whether the mother had a superstitious view of disease or 
not.
Parenta 1_ income and wealthy
Amount (in Dalasie) spent on food per person per day ?
Estimated cash income per month (mother’s estimate) ?
Does mother have a paid maid ?
Does the mother earn a cash salary ?
List consumer items in household (check list provided).
213
APPENDIX II
Variables recorded on the vaccination compliance
questionnaire.
ChiJ.d/s compound^
Distance from health centre ?
Style of house ?
Number of rooms ?
Number of residents ?
Parental educa.tj.giu
Years mother spent at school ?
Years father spent at school ?
Did mother complete primary/secondary/post-secondary
education ?
Did father complete primary/secondary/post-secondary
education ?
Literacy..
(This section was tested, and not simply reported by the 
respondent).
Whether mother/father could read 1.English 2.Arabic 3.Local 
language ?
Whether mother/father could write 1.English 2.Arabic 3.Local 
language ?
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Employment and occupa.tj.gju 
Is mother/father in waged employment ?
Is mother/father self employed ?
What is the nature of mother/father’s employment ?
Income
What is the combined monthly income of the mother and father ?
How many of the following are owed by the mother or the father ?
1.sheep 2.goats 3.cattle 4,land 5.motorcycle 6.bicycle 
7.radio/cassette 8.refrigerator.
Famdl.y structure^
Ethnic group of mother ?
Ethnic group of father ?
Marital status of mother ? Single parent, divorced, 1st, 2nd 
or 3rd wife ?
Number of children born alive to the mother ?
Number of stillbirths experienced by mother ?
Number of deaths among children born to the mother ?
Who was the normal care giver for the child ?
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Attitudes and knowledge^
Mother’s opinion on the causes of childhood disease ?
Mother was asked to name any diseases against which her 
child should be vaccinated.
Where is the child normally taken when he/she is unwell ?
Under which circumstances does the mother take her child to 
the health centre ?
a) when the child is sick ?
b) when the child needed vaccination, even if he/she was not
unwell at that time ?
c) for weighing, even if the child is not unwell ?
Does the mother believe that vaccination can harm the child 
in any way ? If yes - in what ways ?
Had the mother experienced any difficulties or problems at 
the health centre with respect to treatment, vaccinations or 
with the staff ?
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